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A diet high in fruits and vegetables can reduce the risk for 
many leading causes of death (1–3) and can play an important 
role in weight management (4). Healthy People 2010 objectives 
for fruits and vegetables include targets of increasing to 75% 
the proportion of persons aged ≥2 years who consume two or 
more servings of fruit daily and to 50% those who consume 
three or more servings of vegetables daily.* To assess states’ 
progress over the past decade in meeting these targets among 
adults and to provide an update of the 2005 subgroup esti-
mates (5), CDC analyzed data from the Behavioral Risk Factor 
Surveillance System (BRFSS). This report describes the results 
of that analysis, which indicated that, in 2009, an estimated 
32.5% of adults consumed fruit two or more times per day and 
26.3% consumed vegetables three or more times per day, far 
short of the national targets. Overall, the proportion of adults 
who met the fruit target declined slightly, but significantly, from 
34.4% in 2000 to 32.5% in 2009; no significant change was 
observed in meeting the vegetable target. No state met either 
target, and substantial variability occurred among states. Only 
one state had statistically significant increases in the percent-
ages of adults meeting each target. These findings underscore 
the need for interventions at national, state, and community 
levels, across multiple settings (e.g., worksites, community 
venues, and restaurants) to improve fruit and vegetable access, 
availability, and affordability, as a means of increasing individual 
consumption.
BRFSS is an ongoing, state-based, telephone survey of the 
noninstitutionalized U.S. civilian population aged ≥18 years. 
Data are used to monitor the prevalence of health behaviors 
and progress toward national and state-specific health objec-
tives. BRFSS uses a multistage design based on random-digit 
dialing methods to gather a representative sample from each 
state. Data were included from all 50 states and the District 
of Columbia (DC) for years in which the fruit and vegetable 
module was included in the core survey: 2000 (N = 179,139), 
2002 (N = 238,852), 2003 (N = 255,657), 2005 (N = 347,278), 
2007 (N = 420,217), and 2009 (N = 420,968). Median survey 
response rates by state, calculated using Council of American 
Survey Research Organizations (CASRO) guidelines,† were 
48.9% (range: 28.8%–71.8%) for 2000 and 52.5% (range: 
37.9–66.9%) for 2009. Median cooperation rates were 53.2% 
(range: 35.5%–77.7%) for 2000 and 75.0% (range: 55.5%– 
88.0%) for 2009.
For each survey year, prevalence estimates were weighted 
to the respondent’s probability of being selected for the age-, 
race-, and sex-specific distributions for the state based on U.S. 
Census data. Logistic regression analysis was used to assess 
temporal changes in consumption during 2000–2009, includ-
ing year as a continuous variable and controlling for changes in 
state distributions of age through standardization to the 2000 
U.S. standard population; a p-value of <0.05 was used to assess 
statistical significance.
Six BRFSS questions assess fruit and vegetable intake and 
are the only diet intake questions on the core survey: “These 
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next questions are about the foods you usually eat or 
drink. Please tell me how often you eat or drink each 
one, for example, twice a week, three times a month, 
and so forth. How often do you…” 1) “…drink fruit 
juices such as orange, grapefruit, or tomato?” 2) “Not 
counting juice, how often do you eat fruit?” 3) “…
eat green salad?” 4) “…eat potatoes, not including 
French fries, fried potatoes, or potato chips?” 5) “…eat 
carrots?” 6) “Not counting carrots, potatoes, or salad, 
how many servings of vegetables do you usually eat?” 
Consumption was divided by 7 for weekly frequen-
cies, 30 for monthly frequencies, and 365 for yearly 
frequencies to calculate daily consumption. Total daily 
consumption of fruit was the sum of responses to 
questions 1–2 and vegetables the sum of responses to 
questions 3–6. Participants were not given a definition 
of serving size. To be consistent with previous reports, 
respondents who did not answer all six questions and 
those who reported consuming fruits and vegetables 
25 or more times per day were excluded (n = 24,652 
for 2009) from the final sample.
In 2009, an estimated 32.5% of U.S. adults con-
sumed fruit two or more times per day (Table 1), with 
the highest percentage in DC (40.2%) and the lowest 
in Oklahoma (18.1%). The percentage of adults who 
consumed vegetables three or more times per day 
was 26.3%, with the highest percentage in Tennessee 
(33.0%) and the lowest in South Dakota (19.6%). 
Thus, no state met either of the Healthy People 2010 
targets related to fruit and vegetable consumption 
among adults. Twelve states and DC had 35%–45% 
of adults who consumed fruit two or more times per 
day, compared with no states that had 35%–45% of 
adults who consumed vegetables three or more times 
per day (Figure).
From 2000 to 2009, the overall prevalence of 
consuming fruit two or more times per day decreased 
slightly, but significantly, from 34.4% to 32.5% 
(Table 1). Slight but significant increasing linear 
trends for fruit consumption were observed in four 
states, decreasing trends in 22 states and DC, and 
no significant change in 24 states. The prevalence of 
consuming vegetables three or more times per day did 
not change significantly during this period (26.7% 
in 2000 and 26.3% in 2009). Slight but significant 
increasing trends were observed in 11 states and DC, 
decreasing trends in 14 states, and no significant 
change in 25 states. Idaho was the only state that had 
significant, although slight, increases in both fruit and 
vegetable consumption, whereas 10 states had slight 
but significant decreases in both proportions.
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TABLE 1. Percentage of U.S. adults aged ≥18 years who consumed fruit two or more times per day and vegetables three or more times per day, 
by state — Behavioral Risk Factor Surveillance System, 2000–2009*
Fruit two or more times per day Vegetables three or more times per day
State 2000 2002 2003 2005 2007 2009 2000 2002 2003 2005 2007 2009
Overall 34.4 33.5 32.2 32.8 32.9 32.5† 26.7 26.3 26.2 27.1 27.4 26.3
Alabama 25.6 24.0 25.7 23.5 23.9 24.6 30.1 27.8 28.5 27.9 28.5 26.9†
Alaska 31.0 30.6 31.4 33.5 29.9 30.8 25.4 23.8 26.3 24.6 27.7 27.5
Arizona 43.2 31.0 30.8 33.3 33.5 33.7† 38.4 27.1 25.1 26.9 29.9 24.4†
Arkansas 23.5 23.1 22.4 23.3 24.3 24.5 29.4 29.4 28.7 29.1 29.2 26.9
California 40.7 40.4 39.3 40.1 40.6 40.1 23.3 23.5 24.6 26.5 25.6 26.8§
Colorado 33.3 34.6 34.1 33.7 35.4 35.5 25.6 23.6 25.7 25.3 26.5 25.3
Connecticut 43.5 42.2 41.8 37.6 38.6 37.6† 29.2 31.0 30.1 29.9 29.3 28.5
Delaware 34.2 31.9 31.1 28.8 28.9 32.5† 29.8 25.5 26.9 26.5 26.1 27.7
District of Columbia 45.7 43.7 38.3 38.8 41.2 40.2† 26.1 32.5 29.2 31.3 32.8 32.3§
Florida 36.1 36.7 34.5 35.4 36.1 33.3 24.4 27.9 27.4 28.2 29.2 28.3§
Georgia 28.2 27.5 26.2 28.0 27.6 29.9 29.2 29.5 29.8 30.9 30.4 29.5
Hawaii 32.6 29.4 33.1 32.6 39.0 32.9§ 27.0 25.7 36.1 29.5 29.6 26.8
Idaho 27.9 28.4 27.9 30.1 29.3 32.9§ 24.7 25.1 22.8 27.4 25.2 27.8§
Illinois 33.3 33.0 34.7 34.8 36.9 32.4 25.8 22.6 25.4 24.0 23.3 23.3
Indiana 27.7 28.4 29.0 29.2 30.4 28.1 25.5 24.2 25.0 25.2 26.5 23.7
Iowa 28.4 28.5 27.5 28.9 29.9 27.5 21.4 22.6 21.3 23.4 22.4 21.9
Kansas 30.4 24.1 24.9 25.3 23.9 23.8† 29.8 25.9 26.8 26.5 27.2 26.0†
Kentucky 25.0 23.7 22.5 20.5 24.4 24.4 35.5 32.4 31.4 30.2 28.8 29.4†
Louisiana 24.2 23.5 21.5 28.7 28.5 24.6§ 22.8 25.4 25.3 25.9 26.1 21.3
Maine 37.3 37.5 35.9 35.1 36.6 36.0 29.6 30.7 27.9 32.5 31.6 30.6
Maryland 39.0 39.3 37.8 37.6 35.8 36.9† 29.6 31.5 31.4 30.6 28.9 28.7†
Massachusetts 42.7 41.8 39.9 38.9 39.0 36.8† 29.4 29.1 28.2 29.8 28.9 28.1
Michigan 37.3 33.0 29.5 32.2 31.7 32.1† 21.3 21.3 20.5 24.3 23.2 23.9§
Minnesota 37.2 35.2 35.1 36.1 27.2 31.2† 23.3 21.9 23.9 23.1 25.9 26.4§
Mississippi 24.1 22.6 22.1 22.1 24.1 22.9 25.1 25.7 24.0 22.6 22.2 21.6†
Missouri 28.4 23.5 25.2 28.8 25.1 27.3 26.1 26.7 25.7 25.7 26.2 23.0†
Montana 35.4 32.2 29.6 30.6 29.7 33.5† 27.4 26.4 24.1 28.6 28.6 28.0
Nebraska 33.1 31.2 28.5 29.1 33.8 30.2 24.0 22.5 23.0 24.6 26.3 24.3§
Nevada 27.8 33.2 31.0 31.4 30.4 30.3 24.7 21.2 20.8 23.5 24.3 25.5
New Hampshire 39.1 37.7 37.6 37.7 36.3 36.2† 28.5 29.0 28.5 32.3 30.5 30.4
New Jersey 40.3 37.7 37.1 37.4 36.7 36.6† 28.0 27.5 26.3 27.4 29.5 26.2
New Mexico 30.4 30.3 30.1 29.4 27.4 29.8† 23.5 24.8 25.1 26.8 26.3 27.3§
New York 40.7 41.0 37.4 37.6 39.1 38.9† 27.7 24.5 24.2 25.3 27.2 24.7
North Carolina 27.7 28.2 26.9 26.5 25.4 25.0† 32.1 31.2 32.6 32.0 29.7 27.5†
North Dakota 32.2 30.1 30.6 30.4 29.3 31.1 23.8 22.6 22.3 23.8 24.5 24.6
Ohio 30.9 28.6 29.7 30.0 28.5 29.3 24.6 24.5 25.8 25.1 25.2 24.6
Oklahoma 23.3 19.3 17.4 19.6 20.6 18.1† 27.8 25.0 27.4 23.7 24.2 23.5†
Oregon 36.2 35.5 32.5 34.1 33.8 33.0† 27.4 28.2 25.9 29.0 29.8 30.5§
Pennsylvania 33.7 36.9 35.2 33.8 34.9 35.5 25.3 25.0 23.6 26.2 27.1 25.1
Rhode Island 42.8 39.7 37.8 36.3 36.5 36.7† 29.3 27.1 27.7 27.3 26.4 25.9†
South Carolina 29.4 28.5 27.8 25.6 23.8 23.3† 29.9 29.1 26.8 26.2 25.6 22.9†
South Dakota 31.3 30.8 29.2 29.2 25.8 25.2† 25.7 23.4 23.7 24.5 23.9 19.6†
Tennessee 33.8 29.9 25.7 27.2 26.1 26.4† 43.5 39.8 35.3 39.0 37.9 33.0†
Texas 29.1 30.8 28.9 29.4 29.4 30.4 27.4 26.6 26.2 28.5 29.7 27.2
Utah 30.9 31.2 28.5 30.8 32.2 31.5 21.0 20.8 20.4 22.8 24.9 24.4§
Vermont 39.9 39.6 41.6 39.2 38.6 38.9† 29.6 29.4 32.3 31.2 31.8 30.3
Virginia 35.5 33.8 32.6 33.4 33.3 33.7 28.1 31.8 30.0 29.7 30.5 30.3
Washington 35.1 32.9 32.7 34.4 33.8 33.9 23.0 24.8 25.4 27.4 29.2 28.3§
West Virginia 30.0 25.4 23.4 24.7 24.7 25.3† 29.9 29.1 27.7 30.6 25.9 22.1†
Wisconsin 34.0 35.7 32.7 33.4 35.2 34.9 20.3 22.7 20.7 21.1 23.6 23.2§
Wyoming 27.3 29.2 27.8 29.0 32.1 30.3§ 25.6 24.7 26.1 25.9 26.8 26.9
* Results presented are weighted for age, race/ethnicity, and sex. Linear trend analysis includes age-standardized data in the analytic sample from 2000 (N = 174,012), 
2002 (N = 232,743), 2003 (N = 248,255), 2005 (N = 333,032), 2007 (N = 401,450), and 2009 (N = 396,316).
† Significant decreased linear trend (p<0.05).
§ Significant increased linear trend (p<0.05).
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What is already known on this topic?
Fruit and vegetable consumption, although beneficial 
to health, has historically been lower than national 
recommendations.
What is added by this report?
Estimates of fruit and vegetable consumption among 
U.S. adults were far short of Healthy People 2010 
targets, and trends in fruit and vegetable consumption 
over the past decade were relatively flat; no state has 
met the Healthy People 2010 targets.
What are the implications for public health practice?
To meet national targets for fruit and vegetable 
consumption, intensified, multisector (e.g., agricul-
ture, business, food industry, and health care) and 
multisetting (e.g., worksite, school, child care, and 
community) approaches are necessary to improve 
access, availability, and affordability of fruits and 
vegetables.
Overall in 2009, the prevalence of consuming 
fruit two or more times per day or vegetables three 
or more times per day varied substantially by selected 
characteristics (Table 2), with the greatest prevalences 
observed among women (36.1% for fruit two or 
more times per day and 30.9% for vegetables three or 
more times per day), persons aged ≥65 years (41.3% 
and 29.0%), college graduates (36.9% and 32.2%), 
persons with annual household income ≥$50,000 
(32.9% and 29.4%), and persons with a body mass 
index (weight [kg] / height [m2]) <25.0 (36.6% and 
28.3%). Consumption by race/ethnicity varied by 
the type of produce; for example, Hispanics had the 
highest prevalence of fruit consumption (37.2%) 
but the lowest prevalence of vegetable consumption 
(19.7%).
Reported by
KA Grimm, MPH, HM Blanck, PhD, KS Scanlon, 
PhD, LV Moore, PhD, LM Grummer-Strawn, PhD, 
Div of Nutrition, Physical Activity, and Obesity, 
National Center for Chronic Disease Prevention and 
Health Promotion; JL Foltz, MD, EIS Officer, CDC.
Editorial Note
The findings in this report indicate that 2009 
overall and state-specific estimates of the proportions 
of U.S. adults consuming fruit two or more times per 
day or vegetables three or more times per day were 
far short of the targets set by Healthy People 2010; 
furthermore, trends in fruit and vegetable consump-
tion during the past decade were relatively flat. The 
prevalence of fruit and vegetable consumption var-
ied by demographic characteristics and body mass 
index; nonetheless, neither the fruit nor vegetable 
consumption target was met by any of the subgroups 
analyzed.
In 2009, no state met the Healthy People 2010 tar-
gets for fruit or vegetable consumption, and substan-
tial variability occurred among states. These variations 
might be attributed to a number of factors, including 
* Healthy People 2010 target for increasing to 75% the proportion of persons consuming two 
or more servings of fruit daily (objective 19-5).
† Healthy People 2010 target for increasing to 50% the proportion of persons consuming three 
or more servings of vegetables daily (objective 19-6).
FIGURE. Percentage of U.S. adults aged ≥18 years who consumed fruit two or 
more times per day* and vegetables three or more times per day,† by state — 
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differences in population demographics and access, 
availability, and affordability of produce. In addition 
to monitoring progress toward Healthy People 2010 
behavioral targets, CDC monitors policy and envi-
ronmental measures. In 2009, the first state-specific 
data were released on policy and environmental sup-
ports that increase fruit and vegetable consumption. 
The findings in this report indicate that 20 states 
had a state-level food policy advisory council, but 
only eight had enacted healthy food retail policies 
(e.g., tax incentives, low-interest business loans, and 
zoning for stores, markets, and stands) (6), and states 
having farmers markets that accept electronic benefit 
transfers (the system delivering benefits in the federal 
Supplemental Nutrition Assistance Program) ranged 
from zero to 50%.§
To improve access, availability, and affordability 
of fruits and vegetables through retail stores, farmers 
markets, farm-to-institution, worksite food standards, 
and other policy and environmental interventions, 
CDC provides guidance and funding to 25 states.¶ To 
assist these efforts, CDC recently released a guidance 
document on policy and environmental strategies to 
improve fruit and vegetable consumption.** Other 
new federal efforts include the First Lady’s Let’s Move! 
Campaign,†† the U.S. Department of Agriculture’s 
Know Your Farmer, Know Your Food program§§ and 
CDC’s Communities Putting Prevention to Work¶¶ 
program, which help support private and public 
§ CDC state indicator report on fruits and vegetables, 2009: national 
action guide. Available at http://www.fruitsandveggiesmatter.gov/
downloads/nationalactionguide2009.pdf.
 ¶ Available at http://www.cdc.gov/obesity/stateprograms/index.html.
 ** Available at http://www.cdc.gov/nccdphp/dnpao.
 †† Available at http://www.letsmove.gov.
 §§ Additional information available at http://www.usda.gov/wps/
portal/usda/knowyourfarmer?navid=KNOWYOURFARMER.
 ¶¶ Available at http://www.cdc.gov/chronicdisease/recovery/community.
htm.
TABLE 2. Percentage of U.S. adults aged ≥18 years who consumed fruit two or more times per day and vegetables three or more times per day, 
by selected demographic characteristics — Behavioral Risk Factor Surveillance System, 2009
Fruit two or more times per day Vegetables three or more times per day 
Characteristic No. of respondents* % (95% CI†) % (95% CI)
Total 396,316 32.5 (32.2–32.8) 26.3 (26.0–26.6)
Sex
Men 150,404 28.7 (28.3–29.2) 21.4 (20.9–21.8)
Women 245,912 36.1 (35.7–36.4) 30.9 (30.6–31.3)
Age group (yrs)
 18–24 11,827 30.8 (29.4–32.3) 20.1 (19.0–21.4)
 25–34 34,463 31.2 (30.3–32.1) 24.7 (23.9–25.6)
 35–44 55,691 28.8 (28.1–29.5) 26.0 (25.4–26.6)
 45–54 81,065 30.5 (30.0–31.1) 27.6 (27.1–28.2)
 55–64 89,057 32.7 (32.1–33.3) 28.5 (28.0–29.1)
 ≥65 124,213 41.3 (40.9–41.8) 29.0 (28.5–29.4)
Race/Ethnicity
Black, non-Hispanic 29,625 33.7 (32.6–34.9) 21.9 (20.9–22.9)
Hispanic 23,067 37.2 (36.0–38.5) 19.7 (18.7–20.7)
White, non-Hispanic 319,159 31.1 (30.8–31.4) 27.7 (27.4–28.0)
Other race 20,953 36.2 (34.7–37.8) 30.9 (29.5–32.5)
Education
Less than high school diploma 34,890 31.7 (30.6–32.9) 19.5 (18.5–20.5)
High school graduate 117,415 28.9 (28.3–29.5) 21.2 (20.7–21.7)
Some college 107,505 30.8 (30.2–31.4) 26.4 (25.9–27.0)
College graduate 135,976 36.9 (36.4–37.4) 32.2 (31.7–32.7)
Annual household income
 <$25,000 97,929 32.2 (31.5–32.9) 22.0 (21.4–22.6)
 $25,000–$49,999 96,668 31.4 (30.8–32.0) 24.8 (24.3–25.4)
 ≥$50,000 153,945 32.9 (32.4–33.3) 29.4 (29.0–29.8)
Unknown 23,803 32.0 (30.5–33.5) 21.8 (20.6–23.0)
BMI§
<25.0 133,644 36.6 (36.0–37.2) 28.3 (27.8–28.8)
25.0–29.9 (overweight) 139,765 32.0 (31.4–32.5) 25.6 (25.1–26.0)
≥30.0 (obese) 108,381 27.7 (27.2–28.3) 24.3 (23.8–24.8)
* Because of missing data, number of respondents for demographics characteristics might not sum to the total number of respondents in the sample.
† Confidence interval.
§ Body mass index (weight [kg] / height [m2]).
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partners, connect consumers to growers, and prioritize 
interventions at the state and community levels.
Data from the BRFSS dietary screener are used to 
monitor state progress among adults because other 
national surveys do not provide state-specific esti-
mates. Estimates of fruit and vegetable consumption 
obtained from a short food frequency module, such as 
the six-item BRFSS dietary screener described in this 
report, generally are lower than estimates from more 
detailed methods of dietary assessment that record 
all foods (e.g., mixed dishes, soups, and sauces) con-
sumed in a 24-hour period or from longer food fre-
quency questionnaires (e.g., those with 60–120 items) 
(7,8). However, fruit and vegetable intake estimates 
derived with more detailed dietary instruments, such 
as the National Health and Nutrition Examination 
Survey, also reveal flat trends and consumption below 
national targets.***
The findings in this report are subject to at least 
four limitations. First, these results might not be 
generalizable. BRFSS excludes certain populations, 
including persons residing in institutions and without 
landline telephones. Certain subpopulations are more 
likely to be represented in wireless-only households 
(e.g., younger, Hispanic, and lower-income adults) 
(9). Second, dietary history was self-reported and 
subject to social-desirability response bias and recall 
bias. This might have led to overestimates or under-
estimates of prevalence of fruit and vegetable con-
sumption. Third, BRFSS has a low median response 
rate; however, BRFSS weighting procedure partially 
corrects for nonresponse. Finally, only trends in overall 
consumption were examined; trends might vary by 
subpopulation within a state
A number of previous initiatives to promote 
consumption of fruits and vegetables in the United 
States have included individual approaches, such as 
the Fruits and Veggies – More Matters campaign††† 
and single-setting interventions, such as community 
gardens or farmers market voucher programs. Despite 
these initiatives, fruit and vegetable consumption is 
lower than recommended. Thus, intensified, multi-
sector (e.g., agriculture, business, food industry, and 
health care) and multisetting (e.g., worksite, school, 
child care, and community) approaches are necessary 
to facilitate healthier choices among all persons in the 
United States.
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Press; 2001:3–30.
9. CDC. Wireless substitution: early release of estimates from 
the National Health Interview Survey, January–June 2009. US 
Department of Health and Human Services, CDC, National 
Center for Health Statistics; 2009. Available at http://www.cdc.
gov/nchs/data/nhis/earlyrelease/wireless201005.pdf. Accessed 
August 31, 2010.
 *** Additional information available at http://www.cdc.gov/nchs/ppt/
hp2010/focus_areas/fa19_2_ppt/fa19_nutrition2_ppt.htm.
 ††† Additional information available at http://www.fruitsandveggies 
morematters.org.
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During the 2009 influenza A (H1N1) pandemic, 
child care center and school dismissals (i.e., temporary 
closures) were common and occurred in the major-
ity of states across the United States. However, little 
is known about the economic and social problems 
parents face during such dismissals. To learn more 
about parents’ attitudes and experiences after short-
term school dismissals related to H1N1, CDC and 
the Harvard Opinion Research Program (HORP) 
conducted a randomized telephone poll of 523 parents 
from 39 states whose child care center or school had 
been closed temporarily in response to H1N1. This 
report summarizes the results of that poll, which found 
that 90% of parents agreed with the dismissal deci-
sion, and 85% believed dismissal effectively reduced 
influenza transmission. In most cases (58%), dismissal 
lasted ≤3 days. Overall, most parents did not report 
adverse effects related to dismissals of short duration. 
Only 3% of respondents said dismissal was a major 
problem, and 75% reported that it was not a problem. 
Approximately 20% of parents reported that an adult 
in the household missed work because of the dismissal, 
and 19% had a child who missed a free or reduced-
cost lunch, but only 2% and <1%, respectively, said 
these were major problems. The findings in this report 
underscore that when making a decision to close child 
care centers or schools, public health officials should 
consider the acceptability of the resulting disruption 
to students, families, and communities.
During November 19–December 9, 2009, HORP 
conducted a nationwide, random-digit–dialed tele-
phone poll in areas of 39 states identified as having any 
schools reported closed by CDC’s School Dismissal 
Monitoring System.* Social Science Research 
Solutions, a polling company, oversaw field operations. 
Starting from a random sample of residential telephone 
numbers, trained interviewers used screening questions 
to identify 523 parents from all 39 states with a child 
aged <18 years whose child care center or school had 
been closed temporarily in response to H1N1 at any 
time since the opening of school in late summer or 
fall 2009. Telephone calls were made during the day 
and evening on weekdays and weekends, and multiple 
attempts (a mean of six attempts on nonrespond-
ing numbers) were made to reach each respondent 
before considering a telephone number unreachable. 
Respondents answered closed-ended questions during 
a telephone interview lasting approximately 15 min-
utes. To minimize recall bias, the data collection period 
was kept relatively short (3 weeks), and parents were 
polled as close to the period of H1N1-related school 
dismissals as possible; the time since dismissal ranged 
from approximately 1 day to 4 months. The response 
rate was 40.4%.† Data were weighted to match the 
U.S. Census by sex, age, race, education, number of 
children in household, and home ownership,§ and by 
metropolitan area status according to the telephone 
exchange report¶ to mitigate possible nonresponse 
biases (1).
Dismissals lasting ≤3 school days were reported 
by 58% of parents, and 26% reported dismissals for 
≥5 school days (Table 1). Most parents (90%) agreed 
with the school dismissal decision. Among the parents, 
81% believed the major reason for dismissal was to 
reduce transmission of H1N1 by keeping children 
apart, and 85% thought that dismissal was very or 
somewhat effective in reducing the number of cases 
of H1N1 influenza among children in the child care 
center or school.
When asked whether school dismissal overall was 
a problem for their families, 75% responded “not at 
all,” 20% said it was a minor problem, and 3% said 
it was a major problem. When presented with a list 
of possible consequences, 42% reported they had 
experienced one or more associated with dismissal 
(Table 2). The most commonly reported consequences 
faced by parents and families included missed work 
* A daily, web-based or fax report monitoring system developed and 
implemented by CDC and the U.S. Department of Education in 
August 2009. Additional information is available at http://www.
cdc.gov/h1n1flu/schools/dismissal_form.
† The calculation of response rate is based on the following formula: 
(I + P) / (I + P) + (R + NC + O) + (UH + UO); where I = complete 
interviews, P = partial interviews, R = refusal and break off, NC = 
noncontact, O = other numbers (e.g., intended respondent deceased), 
UH = unknown household (not known if household or business 
number), and UO = unknown other. Additional information on 
the methodology used to calculate the response rate is available at 
http://www.aapor.org/response_rates_an_overview.htm.
§ Additional information available at http://www.census.gov/main/ www/ 
cen2000.html.
¶ A telephone exchange report is produced by a company selling 
randomly produced telephone numbers. The report provides an 
estimate of the population in any given exchange (three-digit area 
code plus first three digits).
Parental Attitudes and Experiences During School Dismissals 
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(20%) and child missing free or reduced-cost school 
lunches (19%). Few parents reported feeling at risk of 
losing their job (2%) or having their child miss health 
services usually provided by the school (1%). Overall, 
7% reported any one of the specified issues posed a 
major problem.
Among parents, 4% reported problems arranging 
care for their children (Table 3). Most parents (81%) 
reported that an adult in the household stayed with 
the child for some time during the school dismissal. 
Fewer parents reported that other adults, including 
family members outside the household (20%), a 
neighbor or friend (1%), or a babysitter (3%), stayed 
with the child at least some of the time, and 10% 
reported that their child stayed at home alone at least 
some of the time.
A majority of parents (56%) reported their child 
participated in at least one activity involving persons 
outside the household during the school dismissal 
(Table 3). Children spent time with friends at one 
another’s homes (30%), went grocery shopping (30%), 
and went to fast food restaurants (23%). Fewer parents 
reported children going to public events such as mov-
ies, sporting events, or concerts (17%), large shopping 
areas or malls (15%), or social events such as parties 
or dances (6%).
Reported by
GK Steelfisher, PhD, RJ Blendon, ScD, MM Bekheit, 
JD,Harvard School of Public Health and John F. Ken-
nedy School of Government. N Liddon, PhD, Div of 
STD Prevention, E Kahn, PhD, Div of Global Migra-
tion and Quarantine, R Schieber, MD, Office of Sur-
veillance, Epidemiology, and Laboratory Svcs; K Lubell, 
PhD, Div of Emergency Operations, CDC.
Editorial Note
This report is the first to describe the attitudes 
and experiences of a national sample of parents about 
school dismissals associated with an influenza pan-
demic. Findings from previous studies were limited 
to hypothetical scenarios or local investigations of 
actual dismissals (2–6). The previous studies generally 
found parents anticipated problems with extended 
hypothetical dismissals (6) but experienced relatively 
few problems from actual short-term dismissals (2–4). 
The findings in this report regarding parental support 
and beliefs about reasons for dismissal are similar to 
those reported in local studies of short-term, influenza-
related dismissals in the United States (2–4). When 
deciding whether to close child care centers or schools 
TABLE 1. Characteristics of child care center and school dismissals associated 
with the 2009 influenza A (H1N1) pandemic, and parental attitudes — Harvard 












Don’t know 6 (2)
Child care/After-school activities canceled
Yes 385 (74)
No 93 (17)
No activities 5 (1)
Don’t know 39 (8)
Degree to which dismissal was a problem
Major problem 17 (3)
Minor problem 111 (20)
Not a problem 393 (75)
Don’t know 2 (1)
Agreement with dismissal
Strongly agree 364 (71)
Somewhat agree 108 (19)
Somewhat disagree 33 (7)
Strongly disagree 14 (2)
Don’t know 4 (1)
Perceived as a “major reason” for dismissal§
To reduce transmission by keeping children apart 437 (81)
To reduce transmission by cleaning building and surfaces 390 (73)
Because school cannot operate effectively with high student 
absenteeism
329 (58)
Because school could not operate effectively with high teacher 
absenteeism
194 (36)
Because school would lose funds for high students abstenteeism 159 (35)
Perceived effectiveness of dismissal
Very or somewhat effective 454 (85)
Not very or at all effective 56 (11)
Don’t know 12 (3)
Source of most information about dismissal
Individual school website, newsletter, or e-mail 146 (26)
Local news 120 (24)
School district website or newsletter 99 (20)
Parent listserv or bulletin board 27 (4)
Friends 19 (3)
Family 13 (2)
Local or state public health agency 7 (1)
Child’s pediatrician 3 (1)
Other 82 (17)
None 5 (1)
Don’t know 2 (1)
Level of satisfaction with information
Very satisfied 384 (70)
Somewhat satisfied 104 (20)
Not very satisfied 24 (6)
Not at all satisfied 7 (2)
Don’t know 4 (2)
* Unweighted numbers.
† Data were weighted by sex, age, race, education, number of children in household, home 
ownership, and metropolitan area status. Percentages for a given question might not sum 
to 100% because of rounding or multiple responses.
§ Participants could select more than one response.
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during influenza epidemics, state and local school and 
health authorities should weigh high staff and student 
absenteeism and the health consequences of the dis-
ease and its spread against potential negative conse-
quences of dismissals on families (e.g., missing work 
and disruption of arrangements for care of the child). 
The results of this poll, similar to other studies (2,4), 
show that parental support for short-term child care 
center and school dismissals can be high. However, the 
findings also show that parents might simultaneously 
hold perceptions about the intent of the dismissal that 
might be related to their support. If parents believed 
schools were dismissed for reasons related to absentee-
ism, for example, support might be lower. Support also 
might be contingent on specific community factors, 
dismissal duration, and perceptions about influenza 
risk and severity (2,4). Little evidence for or against 
the effectiveness of school dismissals in interrupting 
influenza transmission is available (7).
Most school dismissals reported in this study were 
brief, which might explain why parents reported few 
problems with missing work or arranging child care. 
Although only 3% of parents said they experienced 
major problems, 10% lost pay or income, and 11% 
incurred additional costs. If the dismissal had lasted 
much longer, economic loss and child care provision 
might have become more important. A 12-day dis-
missal in Australia resulted in approximately half of 
the adults sampled missing work and reporting less 
parental support of school dismissal than described 
in this report (5). In another study, when parents 
considered hypothetical scenarios of prolonged school 
dismissals lasting up to 3 months, substantial propor-
tions of parents had concerns about missing work and 
economic loss (6).
Consistent with other U.S and Australian studies 
(2–5), most parents in this poll reported that their 
child participated in social activities outside the home 
during the dismissal. Whether such congregation 
TABLE 3. Child care arrangements, community sites visited, 
and activities engaged in by children (n = 523) during child 
care center or school dismissals associated with the 2009 
influenza A (H1N1) pandemic — Harvard Opinion Research 
Program Poll, United States, November–December 2009
Activity No.* (%)†
Child care arrangements
Had plan in advance 321 (62)
Had problems arranging care 29 (4)
Who cared for child
Adult in household 403 (81)
Family member outside household 91 (20)
Friend/Neighbor 8 (1)
Professional care provider 18 (3)
Child stayed at home alone 77 (10)
Sites and activities visited by child
Friends’ houses or friends visiting their house 161 (30)
Grocery shopping 154 (30)
Fast food restaurants 105 (23)
Public events (e.g. movies, sporting events, 
or concerts)
78 (17)
Shopping areas or malls 63 (15)
Social events (e.g., parties or dances) 32 (6)
Participated in at least one of these activities 289 (56)
* Unweighted numbers.
† Data were weighted by sex, age, race, education, number of chil-
dren in household, home ownership, and metropolitan area status. 
Percentages for a given question might not sum to 100% because 
of rounding or multiple responses.
TABLE 2. Consequences of child care center or school dismissal associated with the 2009 influenza A (H1N1) pandemic on parents (N = 523) 





Respondents reporting consequence as




No.* (%)† No. (%) No. (%) No. (%) No. (%)
Missed work 111 (20) 12 (2) 64 (11) 35 (7) 412 (80)
Child missed free or reduced-cost school meals 87 (19) 0 (<1) 14 (4) 73 (15) 436 (81)
Incurred financial costs in excess of typical days 61 (11) 13 (2) 40 (8) 8 (1) 462 (89)
Lost pay or income 54 (10) 14 (2) 34 (7) 6 (1) 469 (90)
Missed appointment with potential financial impact 29 (7) 11 (3) 17 (4) 1 (<1) 494 (93)
Missed another kind of important appointment or event 39 (7) 1 (1) 30 (5) 8 (1) 484 (93)
Felt at risk of losing job 10 (2) 6 (1) 4 (1) 0 (0) 513 (98)
Child missed health services usually provided by school 7 (1) 1 (<1) 4 (1) 2 (<1) 516 (99)
Experienced any specified issues§ 213 (42) 34 (7) 116 (24) 79 (13) 310 (58)
* Numbers are unweighted.
† Data were weighted by sex, age, race, education, number of children in household, home ownership, and metropolitan area status. Percentages for a given question 
might not sum to 100% because of rounding or multiple responses.
§ Respondents who experienced one or more of the listed issues/problems.
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poses similar transmission risk as attending child care 
centers or schools is unknown because of differences in 
population density, numbers of contacts, and duration 
and type of physical contact. Although not addressed 
in this poll, parents might be unfamiliar with the 
underlying concept of social distancing and its role 
outside the school environment. Future community 
mitigation efforts should address the public’s basic 
knowledge of school dismissals as part of nonpharma-
ceutical interventions that include social distancing in 
other venues (e.g, workplaces), hand hygiene, covering 
coughs and sneezes, and encouraging ill persons to 
stay at home.
Polls are fielded more quickly and have shorter data 
collection periods than other types of surveys. In the 
context of a pandemic response, this short turnaround 
can facilitate integration of findings into policymak-
ing and refinement of guidance needed during the 
remainder of the pandemic (8). However, the shorter 
data collection period often results in a lower response 
rate, compared with traditional surveys conducted over 
longer periods, and data typically are weighted to key 
demographics. Research suggests that weighted data 
from lower response rate polls conducted within days 
are comparable to data from higher-response surveys 
conducted over longer periods (1). Thus, although 
not frequently used, polling might be an effective 
tool in pandemic and other emergency public health 
responses (8).
The findings in this report are subject to at least 
three limitations. First, these findings might not be 
generalizable to areas with lower levels of influenza 
activity because the poll focused solely on experiences 
and perceptions in areas experiencing school dismissals 
and high levels of influenza activity. Second, sample 
size did not permit assessment of several factors asso-
ciated with parental support of dismissals that might 
be useful to decision makers (e.g., length of dismissal, 
perceived H1N1 severity or risk, urban or rural set-
ting, or child’s age). Finally, the participation rate 
was greater for respondents in certain groups, and 
the weighting might not have addressed nonresponse 
biases completely.
The findings from this poll were presented to the 
National Association of County and City Health 
Officials to assist field staff members in making local 
school dismissal decisions and will be used in devel-
oping future pandemic influenza response guidance. 
When deciding whether to close child care centers 
or schools during influenza pandemics, school and 
health officials collaboratively should consider such 
factors as the level and severity of illness, the need to 
protect staff members and students at high risk, the 
likelihood of high absenteeism, and parental or public 
concerns (9).
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What is already known on this topic?
During the 2009 influenza A (H1N1) pandemic, child 
care center and school dismissals were common 
and occurred in the majority of states across the 
United States, but little is known about the economic 
and social problems that parents face during these 
dismissals.
What does this report add?
A national sample of 523 parents from 39 states found 
that, overall, most did not report adverse effects 
related to school dismissal of short duration. 
What are the implications for public health practice?
When deciding whether to close child care centers or 
schools during influenza epidemics, state and local 
school and health authorities should weigh health 
consequences of the disease and its spread, and high 
staff and student absenteeism, against potential 
negative consequences of dismissals on families, such 
as missing work and arranging for child care.
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premature deaths in the United States annually and 
$193 billion in direct health-care expenditures and 
productivity losses because of premature mortality 
each year.*
Despite significant declines during the past 30 
years, cigarette smoking in the United States continues 
ABSTRACT
Background: Cigarette smoking continues to be the leading cause of preventable morbid-
ity and mortality in the United States, causing approximately 443,000 premature deaths 
annually.
Methods: The 2009 National Health Interview Survey and the 2009 Behavioral Risk Factor 
Surveillance System were used to estimate national and state adult smoking prevalence, 
respectively. Cigarette smokers were defined as adults aged ≥18 years who reported having 
smoked ≥100 cigarettes in their lifetime and now smoke every day or some days.
Results: In 2009, 20.6% of U.S. adults aged ≥18 years were current cigarette smokers. Men 
(23.5%) were more likely than women (17.9%) to be current smokers. The prevalence of 
smoking was 31.1% among persons below the federal poverty level. For adults aged ≥25 
years, the prevalence of smoking was 28.5% among persons with less than a high school 
diploma, compared with 5.6% among those with a graduate degree. Regional differences 
were observed, with the West having the lowest prevalence (16.4%) and higher prevalences 
being observed in the South (21.8%) and Midwest (23.1%). From 2005 to 2009, the 
proportion of U.S. adults who were current cigarette smokers did not change (20.9% in 
2005 and 20.6% in 2009).
Conclusions: Previous declines in smoking prevalence in the United States have stalled 
during the past 5 years; the burden of cigarette smoking continues to be high, especially 
in persons living below the federal poverty level and with low educational attainment. 
Sustained, adequately funded, comprehensive tobacco control programs could reduce 
adult smoking.
Implications for Public Health Practice: To further reduce disease and death from cigarette 
smoking, declines in cigarette smoking among adults must accelerate. The Patient Protection 
and Affordable Care Act is expected to expand access to evidence-based smoking-cessation 
services and treatments; this likely will result in additional use of these services and reductions 
of current smoking and its adverse effects among U.S. adults. Population-based prevention 
strategies such as tobacco taxes, media campaigns, and smoke-free policies, in concert with 
clinical cessation interventions, can help adults quit and prevent the uptake of tobacco use, 
furthering the reduction in the current prevalence of tobacco use in the United States across 
age groups.
Cigarette smoking continues to be the leading 
cause of preventable morbidity and mortality in the 
United States. The negative health consequences of 
cigarette smoking have been well-documented and 
include cardiovascular disease, multiple cancers, 
pulmonary disease, adverse reproductive outcomes, 
and exacerbation of other chronic health conditions 
(1). Cigarette smoking causes approximately 443,000 
Vital Signs: Current Cigarette Smoking Among Adults 
Aged ≥18 Years — United States, 2009
On September 7, this report was posted as an MMWR Early Release on the MMWR website 
(http://www.cdc.gov/mmwr).
* Additional information available at http://www.cdc.gov/tobacco/
data_statistics/fact_sheets/fast_facts/index.htm.
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to be widespread; in 2008, one in five U.S. adults 
(20.6%) were current smokers (2). Year-to-year 
decreases in smoking prevalence have been observed 
only sporadically in recent years. For example, a slight 
decrease occurred from 2006 to 2007 but not from 
2007 to 2008 (2). Monitoring tobacco use is essential 
in the effort to curb the epidemic of tobacco use.† To 
assess progress toward the Healthy People 2010 objec-
tive of reducing the prevalence of cigarette smoking 
among adults to ≤12% (objective 27-1a),§ this report 
provides the most recent national estimates of smok-
ing prevalence among adults aged ≥18 years, based 
on data from the 2009 National Health Interview 
Survey (NHIS), and provides state-level estimates 
based on data from the 2009 Behavioral Risk Factor 
Surveillance System (BRFSS) survey.
Methods
The 2009 NHIS adult core questionnaire collects 
national health information on illness and disability. 
The questionnaire was administered by in-person 
interview and included a random probability sample 
of 27,731 noninstitutionalized civilian adults aged 
≥18 years; the overall response rate was 65.4%. Of 
the 27,731, a total of 128 were excluded because of 
unknown smoking status; thus, the final sample size 
used in the analyses was 27,603. The BRFSS survey is 
a state-based, random-digit–dialed telephone survey 
of the noninstitutionalized civilian adult population 
and collects information on preventive health prac-
tices, health-risk behaviors, and health-care access in 
the United States. The core questionnaire includes 
questions on current cigarette smoking; the Council 
of American Survey and Research Organizations 
(CASRO) median response rate was 52.5% (from 
38.0% in Oregon to 66.9% in Nebraska), and the 
median cooperation rate was 75.0% (55.5% in 
California to 88.0% in Kentucky).¶
Smoking status was defined identically for both 
surveillance systems by using two questions, “Have 
you smoked at least 100 cigarettes in your entire life?” 
and “Do you now smoke cigarettes every day, some 
days, or not at all?” Respondents who had smoked at 
least 100 cigarettes during their lifetime and, at the 
time of interview, reported smoking every day or some 
days were classified as current smokers. Smoking status 
was examined by race/ethnicity, age group, education 
(among persons aged ≥25 years), poverty status, and 
region (overall and by sex). Starting in 2007, income-
related follow-up questions were added to NHIS 
to reduce the number of responses with unknown 
values.** For this report, poverty status was defined 
using 2008 poverty thresholds published by the U.S. 
Census Bureau in 2009; family income was reported 
by the family respondent, who might or might not 
have been the same as the sample adult respondent 
from whom smoking information was collected.
Data from the 2009 NHIS were adjusted for non-
response and weighted to provide national estimates 
of cigarette smoking prevalence; 95% confidence 
intervals were calculated to account for the survey’s 
multistage probability sample design. Data from the 
2009 BRFSS were weighted to adjust for differences 
in probability of selection and nonresponse, as well 
as noncoverage (e.g., households lacking landlines), 
and these sampling weights were used to calculate 
all estimates. Using NHIS data, the Wald test from 
logistic regression analysis was used to analyze tem-
poral changes in current smoking prevalence during 
2005–2009, overall and by region. For this 5-year 
trend analysis, results were adjusted for sex, age, 
and race/ethnicity; a p-value of <0.05 was used to 
determine statistical significance. NHIS results with 
relative standard error of ≥30% are not reported.
Results
In 2009, an estimated 20.6% (46.6 million) of 
U.S. adults were current cigarette smokers; of these, 
78.1% (36.4 million) smoked every day, and 21.9% 
(10.2 million) smoked on some days. Prevalence of 
current smoking was higher among men (23.5%) 
than women (17.9%) (Table). Among racial/ethnic 
groups, Asians had the lowest prevalence (12.0%), and 
Hispanics had a lower prevalence of smoking (14.5%) 
than non-Hispanic blacks (21.3%) and non-Hispanic 
whites (22.1%). Adults reporting multiple races had 
the highest prevalence (29.5%), followed by American 
Indians/Alaska Natives (23.2%).
† Additional information available at http://www.who.int/tobacco/
mpower/mpower_report_full_2008.pdf.
§ Additional information available at http://www.healthypeople.gov/
document/html/objectives/27-01.htm.
¶ Based on Council of American Survey and Research Organizations 
(CASRO) definitions. The response rate is the percentage of persons 
who completed interviews among all eligible persons, including 
those who were not successfully contacted. The cooperation rate 
is the percentage of persons who completed interviews among all 
eligible persons who were contacted.
 ** Additional information available at ftp://ftp.cdc.gov/pub/health_
statistics/nchs/dataset_documentation/nhis/1997/srvydesc.pdf.
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TABLE. Percentage of persons aged ≥18 years who were current cigarette smokers,* by selected characteristics — National Health Interview 
Survey, United States, 2009






Characteristic % (95% CI) % (95% CI†) % (95% CI)
Age group (yrs)       
 18–24 21.8 (19.4–24.2) 28.0 (24.5–31.5) 15.6 (12.9–18.3)
 25–44 24.0 (22.8–25.1) 26.5 (24.7–28.2) 21.5 (20.1–22.9)
 45–64 21.9 (20.7–23.2) 24.5 (22.8–26.2) 19.5 (17.9–21.1)
 ≥65 9.5 (8.5–10.5) 9.5 (8.1–10.9) 9.5 (8.2–10.8)
Race/Ethnicity§       
White, non-Hispanic 22.1 (21.2–23.1) 24.5 (23.2–25.9) 19.8 (18.8–20.8)
Black, non-Hispanic 21.3 (19.6–22.9) 23.9 (21.5–26.2) 19.2 (17.1–21.3)
Hispanic 14.5 (13.2–15.8) 19.0 (16.9–21.1) 9.8 (8.5–11.0)
American Indian/Alaska Native 23.2 (12.9–33.5) 29.7 (15.4–44.0) —¶ —
Asian, non-Hispanic** 12.0 (10.0–14.0) 16.9 (14.0–19.9) 7.5 (4.8–10.3)
Multiple race, non-Hispanic 29.5 (22.9–36.1) 33.7 (24.4–43.0) 24.8 (16.6–33.0)
Education††       
0–12 yrs (no diploma) 26.4 (24.5–28.3) 30.5 (27.6–33.5) 22.2 (19.9–24.5)
≤8 yrs 17.1 (14.5–19.6) 22.2 (18.0–26.4) 11.9 (9.2–14.7)
9–11 yrs 33.6 (30.7–36.5) 36.5 (32.2–40.9) 30.5 (26.6–34.4)
12 yrs (no diploma) 28.5 (23.2–33.9) 34.1 (26.0–42.1) 23.3 (17.0–29.6)
GED§§ 49.1 (44.5–53.8) 53.2 (46.6–59.8) 44.7 (38.2–51.2)
High school graduate 25.1 (23.6–26.5) 29.0 (26.9–31.2) 21.5 (19.8–23.3)
Some college (no degree) 23.3 (21.7–24.9) 26.1 (23.4–28.8) 21.0 (19.0–22.9)
Associate degree 19.7 (17.9–21.5) 20.6 (17.5–23.6) 19.1 (16.5–21.6)
Undergraduate degree 11.1 (10.0–12.3) 12.4 (10.7–14.2) 9.9 (8.3–11.4)
Graduate degree 5.6 (4.6–6.6) 4.9 (3.6–6.3) 6.3 (4.7–7.9)
Poverty status¶¶       
At or above poverty level 19.4 (18.6–20.2) 22.2 (21.1–23.3) 16.7 (15.7–17.6)
Below poverty level 31.1 (29.1–32.9) 34.2 (31.0–37.5) 28.7 (26.5–30.9)
Unspecified 17.3 (15.3–19.3) 22.3 (18.6–26.1) 13.2 (11.0–15.4)
Region***       
Northeast 20.0 (18.0–22.0) 23.4 (20.5–26.3) 16.9 (14.8–19.0)
New England 19.4 (15.2–23.6) 21.5 (14.4–28.6) 17.5 (14.6–20.4)
Mid-Atlantic 20.2 (18.0–22.4) 24.1 (21.1–27.1) 16.7 (14.1–19.3)
Midwest 23.1 (21.6–24.7) 25.7 (23.3–28.1) 20.8 (19.2–22.3)
East North Central 23.8 (22.1–25.5) 26.7 (23.8–29.6) 21.1 (19.5–22.6)
West North Central 21.8 (18.8–24.8) 23.6 (19.7–27.5) 20.1 (16.5–23.7)
South 21.8 (20.7–22.9) 24.5 (22.8–26.2) 19.3 (18.1–20.5)
South Atlantic 20.1 (18.7–21.5) 22.3 (20.1–24.5) 18.0 (16.4–19.6)
East South Central 25.8 (22.7–28.9) 30.1 (25.0–35.2) 22.3 (20.0–24.6)
West South Central 22.5 (20.5–24.5) 25.5 (22.6–28.4) 19.8 (17.4–22.2)
West 16.4 (14.9–17.9) 19.5 (17.6–21.4) 13.3 (11.3–15.2)
Mountain 18.8 (16.0–21.6) 21.7 (18.1–25.3) 16.0 (13.0–19.0)
Pacific 15.3 (13.6–17.0) 18.6 (16.4–20.8) 12.1 (9.7–14.5)
Total 20.6 (19.9–21.3) 23.5 (22.4–24.5) 17.9 (17.1–18.7)
 * Persons who reported smoking at least 100 cigarettes during their lifetimes and who, at the time of interview, reported smoking every day or some days. Excludes 
128 respondents whose smoking status was unknown.
 † 95% confidence interval.
 § Excludes 53 respondents of unknown race.
 ¶ Data not reported because of unstable percentages; relative standard error ≥30%.
 ** Does not include Native Hawaiians or Other Pacific Islanders.
 †† Among persons aged ≥25 years. Excludes 137 persons whose educational level was unknown.
 §§ General Educational Development certificate.
 ¶¶ Family income is reported by the family respondent who might or might not be the same as the sample adult respondent from whom smoking information is 
collected; 2009 estimates are based on reported family income and 2008 poverty thresholds published by the U.S. Census Bureau.
 *** New England: Maine, New Hampshire, Vermont, Massachusetts, Rhode Island, and Connecticut. Mid-Atlantic: New York, Pennsylvania, and New Jersey. East North 
Central: Wisconsin, Michigan, Illinois, Indiana, and Ohio. West North Central: Missouri, North Dakota, South Dakota, Nebraska, Kansas, Minnesota, and Iowa. South 
Atlantic: Delaware, Maryland, District of Columbia, Virginia, West Virginia, North Carolina, South Carolina, Georgia, and Florida. East South Central: Kentucky, Ten-
nessee, Mississippi, and Alabama. West South Central: Oklahoma, Texas, Arkansas, and Louisiana. Mountain: Idaho, Montana, Wyoming, Nevada, Utah, Colorado, 
Arizona, and New Mexico. Pacific: Alaska, Washington, Oregon, California, and Hawaii.
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Variations in smoking prevalence in 2009 were 
observed by education level (Table). Smoking preva-
lence was highest among adults who had obtained a 
General Education Development certificate (GED) 
(49.1%) and generally declined with increasing edu-
cation, being lowest among adults with a graduate 
degree (5.6%). The prevalence of current smoking 
was higher among adults living below the federal 
poverty level (31.1%) than among those at or above 
this level (19.4%). Smoking prevalence did not vary 
significantly for adults aged 18–24 years (21.8%), 
25–44 years (24.0%), and 45–64 years (21.9%); how-
ever, it was lowest for adults aged ≥65 years (9.5%). 
Regionally, smoking prevalence was higher in the 
Midwest (23.1%) and South (21.8%), and lowest 
prevalence for adult current smoking was observed 
for the West (16.4%).
During 2005–2009, the proportion of U.S. adults 
who were current cigarette smokers was 20.9% in 
2005†† and 20.6% in 2009, with no significant dif-
ference (Figure 1). No significant changes in current 
smoking prevalence for U.S. adults were observed 
during the 5-year period overall and for each of the 
four regions: Northeast, Midwest, South, or West 
(p≥0.05).
By state, the prevalence of current smoking ranged 
from 9.8% (Utah) to 25.6% (Kentucky and West 
Virginia) (Figure 2). States with the highest preva-
lence of adult current smoking were clustered in the 
Midwest and Southeast regions.
Conclusions and Comment
The results of these analyses indicate that the 
national estimates for the prevalence of current 
cigarette smoking among adults aged ≥18 years did 
not decline from 2008 (20.6%) (2) to 2009, and 
during the past 5 years (2005–2009) virtually no 
change has been observed, even by region. In 2009, 
certain population subgroups (e.g., Hispanic and 
Asian women, persons with higher levels of educa-
tion, and older adults) continue to meet the Healthy 
People 2010 target of ≤12% prevalence of smoking. 
Although smoking prevalence was found to be lowest 
among Asian and Hispanic women, the findings in 
this report cannot assess specific Asian and Hispanic 
subgroups. In a previous report, variations in smoking 
* Persons who reported smoking at least 100 cigarettes during their lifetimes and who, at the 
time of the survey, reported smoking every day or some days.
FIGURE 1. Percentage of adults aged ≥18 years who were current smokers,* by 
























ture deaths, accounts for up to 30% of cancer 
deaths, and is the single most preventable cause 
of disease and death in the United States.
•	 Despite	 the	adverse	health	effects	of	 smoking	
cigarettes, one in five U.S. adults (46.6 million 
men and women) currently smoke.
•	The	prevalence	of	adult	smoking	is	not	decreas-
ing. Effective population-based strategies to 
encourage cessation (e.g., tobacco taxes, smoke-
free policies, and media campaigns) are essential 
to accelerate the reduction in tobacco use among 
adults in the United States and prevent smoking 
initiation in young persons.
•	 Effective	 cessation	methods	 should	 be	made	
available to increase success rates when tobacco 
users make quit attempts.
•	 Additional	 information	 is	 available	 at	http://
www.cdc.gov/tobacco and http://www.cdc.gov/
vitalsigns.
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prevalence were observed within specific Asian and 
Hispanic subgroups and between the sexes within 
these subgroups, suggesting that overall prevalence 
for Asians and Hispanics do not accurately represent 
the wide variability across subgroups (3).
Differences in understanding the health hazards 
of smoking and receptivity to antismoking mes-
sages might be related to the prevalence variations 
observed by education level (4). For example, persons 
with higher levels of education might have a better 
understanding of the health hazards of smoking and 
might be more receptive to health messaging about the 
dangers of smoking (4). Nonetheless, most popula-
tion subgroups, particularly those with low education 
and income levels, will not meet the Healthy People 
2010 target.
Differences also were noted by state and region. 
In 2009, the lowest prevalence was observed in the 
West, with lowest prevalence in Utah, followed by 
California. California traditionally has been cited 
for its success in tobacco control because of its long-
running comprehensive tobacco control program 
(5). California’s adult smoking prevalence declined 
approximately 40% during 1998–2006, and con-
sequently lung cancer incidence in California has 
been declining four times faster than in the rest of 
the nation (5). Similarly, Maine, New York, and 
Washington have seen 45%–60% reductions in youth 
smoking with sustained comprehensive statewide 
programs (5).
Youth smoking is an important indicator to moni-
tor because most adult established smokers (>80%) 
begin before the age of 18 years.§§ In 2009, one in 
five U.S. high school students (19.5%) reported 
smoking cigarettes in the preceding 30 days (6). 
Moreover, declines in current smoking among high 
school students have slowed, with an 11% decline 
from 21.9% in 2003 to 19.5% in 2009 compared 
with a 40% decline observed from 1997 (36.4%) to 
2003 (21.9%) (7). The slowing in the decline observed 
for youth cigarette smoking indicates that cigarette 
smoking among adults and the associated morbidity 
and mortality will continue to be important public 
health issues for the foreseeable future.
The findings in this report are subject to at least six 
limitations. First, the estimates of cigarette smoking 
were self-reported and were not validated by bio-
chemical tests. However, other studies using levels of 
serum cotinine (a breakdown product of nicotine), 
yield similar prevalence estimates as those obtained 
from self-reports (8). Second, questionnaires are 
administered only in English and Spanish; therefore, 
smoking prevalence for certain racial/ethnic popula-
tions might be overestimated or underestimated if 
English and Spanish are not the primary languages 
spoken. Third, race/ethnicity was not adjusted for 
socioeconomic status. Fourth, because NHIS and 
BRFSS do not include institutionalized populations 
and persons in the military, the results are not general-
izable to these groups. Fifth, BRFSS does not currently 
include adults without telephone service (1.9%) or 
with wireless-only service (13.6%).¶¶ Because adults 
with wireless-only service are more likely to smoke 
cigarettes than the rest of the U.S. population and 
wireless-only service varies by state, state smoking 
prevalence might be underestimated.*** Finally, small 
samples sizes for certain population groups resulted 
in some imprecise estimates. This might explain why 
FIGURE 2. Percentage of persons aged ≥18 years who were current cigarette 






* Persons who reported smoking at least 100 cigarettes during their lifetimes and who, at the 
time of the survey, reported smoking every day or some days.
 §§ Additional information available at http://www.oas.samhsa.gov/
nsduh/2k8nsduh/2k8results.cfm.
 ¶¶ Additional information available at http://www.cdc.gov/nchs/
data/nhsr/nhsr014.pdf.
 *** Additional information available at http://www.cdc.gov/nchs/
nhis.htm.
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the 2009 prevalence estimate for American Indian/
Alaska Native women is lower than prevalence esti-
mates from recent years.
The Healthy People 2010 objective of reducing the 
overall prevalence of cigarette smoking among U.S. 
adults to ≤12% (objective 27-1a) will not be met in 
2010. However, for some subpopulations and states, 
this goal has been reached, demonstrating that the 
national target is achievable. To meet this goal for the 
entire population in the future, evidence-based strate-
gies focused on populations such as persons with lower 
education are needed (5). Effective strategies including 
price increases, comprehensive smoke-free policies, 
and media campaigns to counter pro-tobacco industry 
influences need to be implemented aggressively in 
coordination with providing access to affordable and 
effective cessation treatments and services (5,9). If 
each state sustained comprehensive tobacco control 
programs for 5 years with CDC-recommended levels 
of funding, an estimated 5 million fewer persons in 
the country would smoke, resulting in prevention of 
premature tobacco-related deaths (5).
As this analysis shows, some populations have a 
higher prevalence of cigarette use; thus, a focus on 
reducing tobacco-related disparities also is neces-
sary (5). The Patient Protection and Affordable Care 
Act††† is expected to expand access to evidence-based 
smoking-cessation services and treatments. Given the 
decline in smoking prevalence that was observed after 
the implementation of a mandated tobacco cessation 
coverage for the Massachusetts Medicaid program 
(10), expanded access to cessation services and treat-
ments might result in reductions in current smoking 
and its adverse effects among U.S. adults. For this to 
occur, health professionals need to better identify, 
educate, and offer appropriate cessation services to 
persons who use tobacco.
The enactment of the 2009 Family Smoking 
Prevention and Tobacco Control Act§§§ has provided 
new opportunities for reductions in tobacco use (7,9). 
The Act gives the Food and Drug Administration 
authority to regulate the manufacturing, marketing, 
and distribution of tobacco products. Full imple-
mentation of comprehensive tobacco control policies 
and programs at CDC-recommended levels of fund-
ing (5) would resume progress toward reducing the 
prevalence of smoking in the population.
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nonsmokers remain exposed to secondhand smoke 
in homes, workplaces, public places, and vehicles (1). 
Using data from the National Health and Nutrition 
Examination Survey (NHANES) for 1999–2008, this 
report describes recent trends in secondhand smoke 
exposure among nonsmokers by analyzing levels of 
serum cotinine, a metabolite of nicotine that reflects 
recent exposure.
ABSTRACT
Background: Secondhand exposure to tobacco smoke causes heart disease and lung cancer 
in nonsmoking adults and sudden infant death syndrome, acute respiratory infections, 
middle ear disease, exacerbated asthma, respiratory symptoms, and decreased lung func-
tion in children.
Methods: National Health and Nutrition Examination Survey data from 1999–2008 
were analyzed to determine the proportion of the nonsmoking population with serum 
cotinine (the primary nicotine metabolite) levels ≥0.05 ng/mL, by age, sex, race/ethnicity, 
household income level, and to determine whether the household included a person who 
smoked inside the home.
Results: During 2007–2008, approximately 88 million nonsmokers aged ≥3 years in the 
United States were exposed to secondhand smoke. The prevalence of serum cotinine levels 
≥0.05 ng/mL in the nonsmoking population declined significantly from 52.5% (95% CI = 
47.1%–57.9%) during 1999–2000 to 40.1% (95% CI = 35.0%–45.3%) during 2007–2008. 
The decline was significant for each sex, age, race/ethnicity, and income group studied except 
non-Hispanic whites. The change was greatest from 1999–2000 to 2001–2002. For every 
period throughout the study, prevalence was highest among males, non-Hispanic blacks, 
children (aged 3–11 years) and youths (aged 12–19 years), and those in households below 
the federal poverty level.
Conclusions: Secondhand smoke exposure has declined in the United States, but 88 mil-
lion nonsmokers aged ≥3 years are still exposed, progress in reducing exposure has slowed, 
and disparities in exposure persist, with children being among the most exposed. Nearly 
all nonsmokers who live with someone who smokes inside their home are exposed to 
secondhand smoke.
Implications for public health practice: The only way to protect nonsmokers fully is to 
eliminate smoking in indoor spaces. Continued efforts at smoking cessation and compre-
hensive statewide laws prohibiting smoking in workplaces and public places are needed 
to ensure that all nonsmokers are protected from this serious health hazard. Health-care 
providers should educate patients and parents about the dangers of secondhand smoke and 
follow clinical care guidelines to help smokers quit.
Secondhand exposure to tobacco smoke causes 
heart disease and lung cancer in nonsmoking adults 
and sudden infant death syndrome, acute respiratory 
infections, middle ear disease, exacerbated asthma, 
respiratory symptoms, and decreased lung function in 
children (1). No risk-free level of secondhand smoke 
exposure exists (1). Levels of secondhand smoke expo-
sure among U.S. nonsmokers have fallen substantially 
during the past 20 years (2). However, millions of 
Vital Signs: Nonsmokers’ Exposure to Secondhand Smoke — 
United States, 1999–2008
On September 7, this report was posted as an MMWR Early Release on the MMWR website 
(http://www.cdc.gov/mmwr).
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Methods
NHANES produces data for a nationally rep-
resentative sample of the noninstitutionalized U.S. 
civilian population every 2 years. NHANES surveys 
include a home interview, physical examination at a 
mobile examination center where biologic specimens 
are collected, and laboratory specimen testing, includ-
ing serum cotinine analysis for participants aged ≥3 
years. Response rates exceeded 75% for all 2-year 
study cycles.* From the 1999–2000, 2001–2002, 
2003–2004, 2005–2006, and 2007–2008 NHANES 
cycles, 30,451 respondents were determined to be 
nonsmokers (by cotinine level ≤10 ng/mL and self-
reported history for persons aged ≥12 years) and were 
included in the analysis.
Serum cotinine was analyzed using an isotope 
dilution liquid chromatography tandem mass spec-
trometry method (2). Cotinine concentrations below 
a level known as the limit of detection (LOD) might 
be estimated inaccurately. The cotinine LOD initially 
was 0.05 ng/mL and changed to 0.015 ng/mL after 
improvements to the method. Cotinine levels below 
the LOD were reported as LOD / √2; this value 
represents the approximate midpoint of the interval 
between zero and LOD on a log scale.
Serum cotinine levels >10 ng/mL are associated 
with active smoking within the past few days (3). 
Therefore, children aged 3–11 years were assumed to be 
nonsmokers if their serum cotinine concentration was 
≤10 ng/mL. Youths aged 12–19 years were considered 
nonsmokers if their serum cotinine concentration was 
≤10 ng/mL and they did not report smoking within 
the preceding 30 days or use of any nicotine-containing 
product within the preceding 5 days at their physical 
examination. Adults aged ≥20 years were considered 
nonsmokers if their serum cotinine concentration was 
≤10 ng/mL and they did not report being a current 
smoker during their home interview or report use of 
any nicotine-containing product within the preceding 
5 days at their physical examination.
The percentage of the nonsmoking population 
with serum cotinine levels ≥0.05 ng/mL, the higher 
LOD, was calculated by survey cycle, sex, race/eth-
nicity group, age group, household income level, and 
whether households contained a person who smoked 
inside the home; 95% confidence intervals (CIs) 
were calculated using a log transformation for values 
>98% and the Wald method otherwise. Sample sizes 
are insufficient to allow separate reporting for race/
ethnicity groups other than non-Hispanic whites, 
non-Hispanic blacks, and Mexican-Americans, but 
all race/ethnicity groups are included in the reported 
values for the total population and the values shown 
by sex, age group, and household income level. For 
2007–2008, the most recently completed NHANES 
cycle, the number of nonsmokers with serum coti-
nine ≥0.05 ng/mL was calculated by age group using 
the midpoint population as the denominator, and 
the distribution of serum cotinine concentrations 
was examined separately for nonsmokers who lived 
with and without someone who smoked inside the 
home.
Two-sided t-tests were used to assess differences 
between population group percentages within study 
cycles and differences within population groups across 
study cycles; p<0.05 was considered statistically sig-
nificant. Data analyses accounted for the complex 
survey design, differential probability of sample selec-
tion, nonresponse, and sample noncoverage.
Results
The overall prevalence of serum cotinine concen-
trations ≥0.05 ng/mL among the nonsmoking popu-
lation fell from 52.5% (CI = 47.1%–57.9%) during 
1999–2000 to 40.1% (CI = 35.0%–45.3%) during 
2007–2008 (Table 1). However, the decline occurred 
only among the subset of the nonsmoking population 
that did not live with someone who smoked inside 
the home. The decline was significant for each sex, 
age, race/ethnicity, and income group studied except 
non-Hispanic whites. Prevalence fluctuated from cycle 
to cycle rather than showing a consistent decline; the 
greatest decline (10.8% percentage points) occurred 
from 1999–2000 to 2001–2002.
For every survey cycle, a significantly higher preva-
lence of cotinine concentrations ≥0.05 ng/mL was 
observed among males than among females, among 
non-Hispanic blacks than among non-Hispanic 
whites and Mexican-Americans, among children aged 
3–11 years and youths aged 12–19 years than among 
adults aged ≥20 years, and among those below the 
federal poverty level than among those at or above 
the poverty level.
During 2007–2008, approximately 88 million 
nonsmokers aged ≥3 years in the United States were 
exposed to secondhand smoke (CI = 76 million–99 
million) (Table 2). Of these, 32 million were aged 
3–19 years, reflecting the higher prevalence of 
* Additional information available at http://www.cdc.gov/nchs/
nhanes/response_rates_cps.htm.
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exposure among children and youths. Similarly, 
among nonsmoking adults, the prevalence of exposure 
decreased with age so that there were approximately 
21–22 million exposed persons in each of the 20–39 
year and 40–59 year age groups and approximately 14 
million exposed persons in the ≥60 year age group.
Children and nonsmoking youths were more 
likely than nonsmoking adults to live with someone 
who smoked inside the home. During 2007–2008, 
18.2% (CI = 11.2%–25.3%) of children aged 3–11 
years and 17.1% (CI = 12.7%–21.4%) of youths aged 
12–19 years lived with someone who smoked inside 
the home, compared with 5.4% (CI = 3.8%–7.0%) 
of adults aged ≥20 years. The majority (96.0%; CI 
= 93.3%–98.6%) of nonsmokers who lived with 
someone who smoked inside the home had cotinine 
levels ≥0.05 ng/mL (Figure). Among nonsmoking 
children and youths living with someone who smoked 
inside the home, 98.3% (CI = 95.5%–99.3%) had 
serum cotinine ≥0.05 ng/mL, compared with 39.9% 
(CI = 34.3%–45.4%) among those not living with 
someone who smoked inside the home (p<0.05). For 
nonsmoking adults, the corresponding prevalences 
were 93.4% (CI = 89.2%–97.5%) and 33.4% (CI = 
29.1%–37.8%), respectively (p<0.05).
Conclusions and Comment
This is the first reported analysis of 2007–2008 
cotinine levels among the full U.S. nonsmoking 
population aged ≥3 years. The results confirm that 
secondhand smoke exposure in the United States is 
far less prevalent at 40% than during 1988–1991, 
when 88% of the nonsmoking population age ≥4 
years had serum cotinine levels ≥0.05 ng/mL (2). 
This decline is attributable to a number of factors, 
including decreased smoking prevalence, increases in 
TABLE 1. Percentage of the nonsmoking population aged ≥3 years with serum cotinine levels ≥0.05 ng/mL, by selected characteristics — 
National Health and Nutrition Examination Survey, United States, 1999–2008
% with serum cotinine ≥0.05 ng/mL (95% CI*)
Characteristic 1999–2000 2001–2002 2003–2004 2005–2006 2007–2008
Total  52.5 (47.1–57.9)  41.7 (35.5–47.9)  47.6 (40.3–54.9)  39.1 (35.6–42.7)  40.1 (35.0–45.3)
Sex
Male  58.5 (52.1–64.9)  45.5 (38.9–52.1)  51.9 (44.3–59.5)  43.0 (39.1–46.9)  43.5 (37.5–49.4)
Female  47.5 (42.5–52.5)  38.6 (32.4–44.7)  44.2 (36.8–51.6)  35.9 (31.6–40.2)  37.4 (32.6–42.2)
Age group (yrs)      
 3–11  64.9 (56.0–73.9)  55.7 (47.1–64.2)  64.8 (55.5–74.2)  50.8 (45.4–56.1)  53.6 (46.2–61.0)
 12–19  63.1 (56.4–69.7)  46.9 (36.6–57.1)  57.1 (50.3–63.9)  45.4 (38.7–52.1)  46.5 (38.3–54.8)
 ≥20  48.0 (42.6–53.4)  37.8 (31.7–44.0)  42.4 (35.1–49.8)  35.8 (32.5–39.1)  36.7 (32.0–41.3)
Race/Ethnicity      
White, non-Hispanic  49.6 (42.4–56.7)  36.3 (29.4–43.1)  45.9 (36.6–55.3)  36.6 (32.3–40.8)  40.1 (32.2–48.0)
Black, non-Hispanic  74.2 (70.2–78.2)  71.8 (66.7–77.0)  68.1 (59.7–76.4)  60.2 (53.0–67.3)  55.9 (50.6–61.3)
Mexican-American  44.3 (37.4–51.1)  39.9 (30.1–49.7)  34.0 (25.5–42.5)  33.8 (26.5–41.1)  28.5 (23.1–33.9)
Poverty status      
Below poverty level  71.6 (64.8–78.5)  60.2 (47.1–73.3)  63.6 (55.0–72.2)  62.7 (57.1–68.4)  60.5 (55.0–66.0)
At or above poverty level  48.8 (42.8–54.8)  38.4 (32.9–44.0)  44.8 (37.7–52.0)  35.9 (32.7–39.1)  36.9 (31.3–42.5)
Unspecified  53.5 (48.4–58.6)  44.1 (32.7–55.5)  50.5 (36.4–64.6)  42.0 (29.0–55.0)  39.6 (30.8–48.5)
* Confidence interval.
TABLE 2. Percentage and estimated number of nonsmokers with serum cotinine levels ≥0.05 ng/mL, by age group — National Health and 
Nutrition Examination Survey, United States, 2007–2008
Age group (yrs)
% with serum 
cotinine ≥0.05 ng/mL
No. of nonsmokers 
in population (millions)*
No. of nonsmokers with serum 
cotinine ≥0.05 ng/mL (millions) (95% CI†)
≥3 40.1 218 88 (76–99)
3–19 50.2 64 32 (28–37)
3–11 53.6 36 19 (17–22)
12–19 46.5 28 13 (11–16)
≥20 36.7 156 57 (50–64)
20–39 42.8 52 22 (20–25)
40–59 35.4 60 21 (18–24)
≥60 31.6 44 14 (11–17)
* Totals do not sum exactly because of rounding.
† Confidence interval.
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the number of local and state laws prohibiting smok-
ing in indoor workplaces and public places, increases 
in voluntary smoking restrictions in workplaces and 
homes, and changes in public attitudes regarding 
social acceptability of smoking near nonsmokers 
and children (1). Although prevalence of exposure 
has dropped for children and non-Hispanic blacks, 
groups that traditionally have had higher-than-average 
exposure levels (1–4), disparities remain. Further, 
this report shows that millions of nonsmokers in the 
United States remain exposed to secondhand smoke, 
including nearly all of those who live with someone 
who smokes inside the home.
Workplaces and homes usually are the most 
important sources of secondhand smoke exposure 
among adults because these are the settings where 
they typically spend the most time (1). The number 
of state, local, and voluntary smoke-free policies has 
greatly increased in recent years and has helped to 
protect nonsmokers from the toxicants in second-
hand smoke. Nonetheless, currently only 24 states 
and the District of Columbia have comprehensive 
smoke-free laws covering workplaces, restaurants, 
and bars†; complete statewide bans are needed in the 
remaining 26 states because only 47% of the national 
population is covered by comprehensive state or local 
FIGURE. Serum cotinine levels among nonsmoking persons aged ≥3 years — 
National Health and Nutrition Examination Survey, United States, 2007–2008
Persons not living with a person who smokes inside the home
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Key Points
•	 Despite	progress	in	protecting	nonsmokers	from	
secondhand smoke, approximately 88 million 
nonsmokers (including 32 million children and 
youths) in the United States were exposed to 
secondhand smoke during 2007–2008.
•	 Children	 are	more	 likely	 than	 nonsmoking	
adults to live with someone who smokes inside 
the home and more likely to be exposed to 
secondhand smoke.
•	The	vast	majority	of	nonsmokers	who	live	with	
persons who smoke inside the home are exposed 
to secondhand smoke.
•	 Exposure	 to	 secondhand	 smoke	 causes	 heart	
disease and lung cancer in nonsmoking adults 
and sudden infant death syndrome, acute respi-
ratory infections, middle ear disease, exacerbated 
asthma, respiratory symptoms, and decreased 
lung function in children.
•	 No	risk-free	level	of	secondhand	smoke	exposure	
exists.
•	The	only	way	 to	 protect	 nonsmokers	 fully	 is	
to eliminate smoking in indoor spaces, includ-
ing workplaces, public places (e.g., restaurants 
and bars), and private places (e.g., homes and 
vehicles) through smoke-free laws and policies 
and through decreased smoking prevalence.
•	 Additional	 information	 is	 available	 at	http://
www.cdc.gov/vitalsigns.
 † Additional information available at http://apps.nccd.cdc.gov/
statesystem.
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laws.§ Smoke-free policies have been shown to greatly 
reduce the probability and amount of exposure to 
secondhand smoke in workplaces and public places, 
as well as adverse health events.¶ Workplace smoking 
restrictions lead to smoking reductions and cessation 
among workers.** However, smoke-free policies do 
not eliminate secondhand smoke exposure from all 
sources. As workplaces and public places increasingly 
are made smoke-free, private settings such as homes 
and vehicles are becoming relatively larger sources of 
overall exposure (1).
The home is the major source of secondhand 
smoke exposure for children (1). During 1988–1994, 
fewer than 1% of children aged 4–16 years living with 
persons who smoked inside the home had cotinine 
levels <0.05 ng/mL (5). The findings in this report 
demonstrate that currently approximately 1.7% of 
nonsmoking children and youths (aged 3–19 years) 
living with someone who smoked inside the home had 
cotinine levels <0.05 ng/mL. Thus, among children 
living with persons who smoked inside the home, the 
likelihood of exposure has not changed appreciably 
during the past 20 years. The stall in the decline of 
adult smoking prevalence and the persistence of smok-
ing in homes likely are impeding progress toward full 
protection of children and other nonsmokers from 
secondhand smoke exposure. Based on evidence that 
providing parents with information about the harms 
of secondhand smoke reduces children’s exposure, 
the American Academy of Pediatrics and the U.S. 
Public Health Service recommend that clinicians ask 
parents about their smoking, advise them about the 
harms of secondhand smoke, and offer encourage-
ment and help in quitting according to clinical care 
guidelines (6,7).
Previous studies have noted that non-Hispanic 
black nonsmokers tend to have higher cotinine lev-
els than nonsmokers of other race/ethnicity groups 
(1,2). The reasons for this difference are not known, 
but some evidence suggests that slower metabolism 
or clearance of cotinine might result in blacks hav-
ing higher cotinine levels for a given amount of 
exposure (8). Other possible reasons relate to levels 
of protection from exposure at home, in vehicles, and 
in public places or workplaces.
The findings in this report are subject to at least 
two limitations. First, nonsmoking status was defined 
based on self-report and cotinine levels. Self-reports 
might be inaccurate; similarly, any cotinine cutpoint 
might misclassify some persons. The optimal coti-
nine cutpoint might vary by race/ethnicity and age 
group, and is dependent upon background levels 
of secondhand smoke (1,8). This analysis used the 
10 ng/mL cutpoint to be consistent with previous 
analyses (1–4). Using self-report and cotinine levels 
in combination should have minimized misclassifica-
tion. Second, the sample size was insufficient to allow 
calculation of trends for all race/ethnicity groups. 
Smoking prevalence varies widely across and within 
race/ethnicity groups (9) and by region (10); second-
hand smoke exposure rates are similarly variable (1). 
Also, variability in secondhand smoke exposure across 
population subgroups might have contributed to the 
observed fluctuation in prevalence during the study 
period because NHANES is not designed to have the 
same regional distribution in every cycle.
Healthy People 2010 objective 27-10 is to reduce 
the percentage of the nonsmoking population exposed 
to secondhand smoke (i.e., those with serum cotinine 
levels ≥0.05 ng/mL) to ≤56%.†† This target has been 
met, but disparities in exposure persist. Nonsmokers 
who live and work in places lacking smoke-free laws or 
policies continue to be exposed to secondhand smoke 
(1). The only way to protect nonsmokers fully is to 
eliminate smoking in indoor spaces (1).
Several federal government initiatives are cur-
rently addressing this issue. For example, in 2010, 
funds from the American Recovery and Reinvestment 
Act were made available to all 50 states, the District 
of Columbia, seven U.S. territories, and 21 com-
munities to address tobacco control. As part of this 
Communities Putting Prevention to Work Initiative, 
grantees that do not already have comprehensive 
smoke-free policies covering workplaces and public 
places are working toward adopting such poli-
cies. The U.S. Department of Housing and Urban 
Development issued a notice§§ encouraging public 
housing authorities to implement no-smoking policies  § Additional information available at http://www.no-smoke.org/
pdf/SummaryUSPopList.pdf.
 ¶ Additional information available at http://www.iom.edu/reports/ 
2009/secondhand-smoke-exposure-and-cardiovascular-effects-
making-sense-of-the-evidence.aspx.
 ** Additional information available at http://www.iarc.fr/en/publications/ 
pdfs-online/prev/handbook13/handbook13.pdf.
 †† Additional information available at http://wonder.cdc.gov/data 
2010.
 §§ Available at http://www.hud.gov/offices/pih/publications/notices/ 
09/pih2009-21.pdf.
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in 2009. The U.S. Environmental Protection Agency 
conducts a national campaign that educates and 
encourages parents to make their homes smoke-free 
to protect their children’s health.¶¶ Continued efforts 
to reduce secondhand smoke exposure in all settings 
are needed to ensure that all nonsmokers are protected 
from this hazard.
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Announcement
Sickle Cell Awareness Month — 
September, 2010
September is Sickle Cell Awareness Month. This 
year marks the 100th anniversary of the seminal case 
report published in the Archives of Internal Medicine 
(November 1910) by James B. Herrick titled “Peculiar 
Elongated and Sickle-Shaped Red Blood Corpuscles 
in a Case of Severe Anemia.”
Sickle cell disease is an inherited blood disorder that 
affects an estimated 70,000 to 100,000 persons in mul-
tiple racial and ethnic populations in the United States 
(1). In the United States, one in 500 persons in the black 
population is born with the disease. Other populations 
affected include Hispanics, persons of Mediterranean 
and Middle Eastern descent, and Asians. In addition, 
approximately 2 million persons in the United States 
have the sickle cell trait. Sickle cell disease is inherited 
in an autosomal recessive pattern. A person with one 
copy of the mutated gene for hemoglobin is commonly 
referred to as having the sickle cell trait. The trait typi-
cally is asymptomatic, and persons with the trait com-
monly are unaware of their carrier status. However, these 
persons might pass the gene on to their children. 
No data system exists that can be used to deter-
mine the actual prevalence of sickle cell disease in 
the United States. CDC, in partnership with the 
National Institutes of Health, is developing a pilot 
surveillance project that will help determine more 
about how many persons have the disease and how 
it affects them. The Registry and Surveillance System 
for Hemoglobinopathies (RuSH) is funding the proj-
ect in six states: California, Florida, Georgia, North 
Carolina, Michigan, and Pennsylvania.
In recognition of Sickle Cell Awareness Month 
and commemoration of the 100th anniversary of 
the seminal case report, CDC is sponsoring activities 
to increase knowledge and awareness of the disease, 
including a symposium on September 13, 2010, in 
Atlanta, Georgia. Additional information regarding 
sickle cell disease and the symposium is available at 
http://www.cdc.gov/sicklecell.
Reference
1. National Heart, Lung, and Blood Institute. Disease and 
conditions index. Sickle cell anemia: who is at risk? Bethesda, 
MD: US Department of Health and Human Services, National 
Institutes of Health, National Heart, Lung, and Blood Institute; 
2010. Available at http://www.nhlbi.nih.gov/health/dci/
Diseases/Sca/SCA_WhoIsAtRisk.html.
Errata: Vol. 59, No. RR-8
In the MMWR Recommendations and Reports 
“Prevention and Control of Influenza with Vaccines: 
Recommendations of the Advisory Committee on 
Immunization Practices (ACIP), 2010,” multiple 
errors occurred. On page 3, in the second column, the 
fifth sentence of the first full paragraph should read, 
“However, randomized placebo-controlled trials can-
not be performed ethically in populations for which 
vaccination already is recommended, and in this 
context, observational studies that assess outcomes 
associated with laboratory-confirmed influenza infec-
tion also can provide important vaccine or antiviral 
safety and effectiveness data.” On page 10, in the 
second column, the sixth sentence of the paragraph 
headed “Evaluating Influenza Vaccine Efficacy and 
Effectiveness Studies” should read, “Randomized 
placebo-controlled trials that measure laboratory-
confirmed influenza virus infections as the outcome 
are the most persuasive evidence of vaccine efficacy, 
but such trials cannot be conducted ethically among 
groups recommended to receive vaccine annually.” On 
page 34, the first footnote for Figure 3 should read, 
“Reprinted with permission. American Academy of 
Pediatrics, Committee on Infectious Diseases. Policy 
statement: recommendations for prevention and con-
trol of influenza in children, 2010–2011. Available 
at http://pediatrics.aappublications.org/cgi/reprint/
peds.2010-2216v1.”
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QuickStats 
FROM THE NATIONAL CENTER FOR HEALTH STATISTICS
Percentage of Youths Aged 5–17 Years Ever Diagnosed as Having a Learning 
Disability and/or Attention Deficit Hyperactivity Disorder (ADHD),* by Sex — 
National Health Interview Survey, United States, 2006–2009
* Estimates are based on household interviews of a sample of the civilian, noninstitutionalized U.S. population. 
One child aged <18 years was randomly selected per family; a parent or other knowledgeable adult provided 
information for each child.  Prevalences of learning disability and attention deficit hyperactivity disorder (ADHD) 
are based on questions that asked, “Has a representative from a school or a health professional ever told you 
that (the sample child) had a learning disability?“ and “Has a doctor or health professional ever told you that 
(the sample child) had ...attention deficit hyperactivity disorder (ADHD) or attention deficit disorder (ADD)?,” 
respectively. Unknowns with respect to learning disability and ADHD are excluded from the denominators.  
† 95% confidence interval. 
Among youths aged 5–17 years, during 2006–2009, boys were twice as likely as girls (18.2% versus 9.2%) to have been diagnosed 
with either a learning disability or attention deficit hyperactivity disorder (ADHD). Approximately 5.7% of boys had a learning 
disability without ADHD, compared with 3.9% of girls, 7.0% of boys had ADHD without a learning disability compared with 2.8% 
of girls, and 5.5% of boys had both a learning disability and ADHD compared with 2.5% of girls. 
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TABLE I. Provisional cases of infrequently reported notifiable diseases (<1,000 cases reported during the preceding year) — United States, week ending 









Total cases reported 
for previous years States reporting cases 
during current week (No.)2009 2008 2007 2006 2005
Anthrax — — 0 1 — 1 1 —
Botulism, total — 55 3 118 145 144 165 135
 foodborne — 5 1 10 17 32 20 19
 infant — 38 2 83 109 85 97 85
 other (wound and unspecified) — 12 1 25 19 27 48 31
Brucellosis 1 82 2 115 80 131 121 120 CA (1)
Chancroid — 31 0 28 25 23 33 17
Cholera — 2 0 10 5 7 9 8
Cyclosporiasis§ — 128 3 141 139 93 137 543
Diphtheria — — — — — — — —
Domestic arboviral diseases § ,¶:
 California serogroup virus disease — 21 4 55 62 55 67 80
 Eastern equine encephalitis virus disease — 9 1 4 4 4 8 21
 Powassan virus disease — 2 0 6 2 7 1 1
 St. Louis encephalitis virus disease — 3 1 12 13 9 10 13
 Western equine encephalitis virus disease — — — — — — — —
Haemophilus influenzae,** invasive disease (age <5 yrs):
 serotype b — 9 0 35 30 22 29 9
 nonserotype b 1 128 3 236 244 199 175 135 OH (1)
 unknown serotype 2 154 2 178 163 180 179 217 FL (2)
Hansen disease§ — 29 1 103 80 101 66 87
Hantavirus pulmonary syndrome§ — 14 1 20 18 32 40 26
Hemolytic uremic syndrome, postdiarrheal§ 4 123 8 242 330 292 288 221 NY (1), TN (1), CA (2)
HIV infection, pediatric (age <13 yrs)†† — — 1 — — — — 380
Influenza-associated pediatric mortality§,§§ — 56 1 358 90 77 43 45
Listeriosis 10 512 22 851 759 808 884 896 NY (3), PA (1), OH (1), FL (1), TX (2), OR (1), CA (1)
Measles¶¶ — 48 1 71 140 43 55 66
Meningococcal disease, invasive***:
 A, C, Y, and W-135 1 174 4 301 330 325 318 297 FL (1)
 serogroup B — 77 2 174 188 167 193 156
 other serogroup — 7 0 23 38 35 32 27
 unknown serogroup 4 266 7 482 616 550 651 765 OH (2), MD (1), KY (1)
Mumps 3 2,321 15 1,991 454 800 6,584 314 NY (3)
Novel influenza A virus infections††† — 1 0 43,774 2 4 NN NN
Plague — 1 0 8 3 7 17 8
Poliomyelitis, paralytic — — — 1 — — — 1
Polio virus Infection, nonparalytic§ — — — — — — NN NN
Psittacosis§ — 4 0 9 8 12 21 16
Q fever, total§,§§§ 2 78 3 114 120 171 169 136
 acute 2 59 1 94 106 — — — FL (1), CA (1)
 chronic — 19 0 20 14 — — —
Rabies, human — — 0 4 2 1 3 2
Rubella¶¶¶ — 5 0 3 16 12 11 11
Rubella, congenital syndrome — — — 2 — — 1 1
SARS-CoV§,**** — — — — — — — —
Smallpox§ — — — — — — — —
Streptococcal toxic-shock syndrome§ 2 120 1 161 157 132 125 129 NY (1), VA (1)
Syphilis, congenital (age <1 yr)†††† — 135 8 423 431 430 349 329
Tetanus — 4 1 18 19 28 41 27
Toxic-shock syndrome (staphylococcal)§ 1 53 2 74 71 92 101 90 OH (1)
Trichinellosis — 2 0 13 39 5 15 16
Tularemia 1 65 3 93 123 137 95 154 CA (1)
Typhoid fever 4 252 12 397 449 434 353 324 NY (1), PA (1), CA (2)
Vancomycin-intermediate Staphylococcus aureus§ — 63 1 78 63 37 6 2
Vancomycin-resistant Staphylococcus aureus§ — 1 — 1 — 2 1 3
Vibriosis (noncholera Vibrio species infections)§ 12 459 15 789 588 549 NN NN MD (1), GA (1), FL (5), TX (1), OR (1), CA (3)
Viral hemorrhagic fever§§§§ — 1 — NN NN NN NN NN
Yellow fever — — — — — — — —
See Table I footnotes on next page.
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Notifiable Disease Data Team and 122 Cities Mortality Data Team
 Patsy A. Hall-Baker
Deborah A. Adams  Rosaline Dhara
Willie J. Anderson  Pearl C. Sharp
Michael S. Wodajo  Lenee Blanton
* Ratio of current 4-week total to mean of 15 4-week totals (from previous, comparable, and subsequent 4-week periods for the 
past 5 years). The point where the hatched area begins is based on the mean and two standard deviations of these 4-week 
totals.
FIGURE I. Selected notifiable disease reports, United States, comparison of provisional 4-week 



























TABLE I. (Continued) Provisional cases of infrequently reported notifiable diseases (<1,000 cases reported during the preceding year) — United States, week 
ending September 4, 2010 (35th week)*
—: No reported cases. N: Not reportable. NN: Not Nationally Notifiable Cum: Cumulative year-to-date counts.
 * Incidence data for reporting years 2009 and 2010 are provisional, whereas data for 2005 through 2008 are finalized.
 † Calculated by summing the incidence counts for the current week, the 2 weeks preceding the current week, and the 2 weeks following the current week, for a total of 5 preceding years. 
Additional information is available at http://www.cdc.gov/ncphi/disss/nndss/phs/files/5yearweeklyaverage.pdf.
 § Not reportable in all states. Data from states where the condition is not reportable are excluded from this table except starting in 2007 for the domestic arboviral diseases, STD data, TB 
data, and influenza-associated pediatric mortality, and in 2003 for SARS-CoV.  Reporting exceptions are available at http://www.cdc.gov/ncphi/disss/nndss/phs/infdis.htm.
 ¶ Includes both neuroinvasive and nonneuroinvasive. Updated weekly from reports to the Division of Vector-Borne Infectious Diseases, National Center for Zoonotic, Vector-Borne, and 
Enteric Diseases (ArboNET Surveillance). Data for West Nile virus are available in Table II.
 ** Data for H. influenzae (all ages, all serotypes) are available in Table II.
 †† Updated monthly from reports to the Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Implementation of HIV reporting influences 
the number of cases reported. Updates of pediatric HIV data have been temporarily suspended until upgrading of the national HIV/AIDS surveillance data management system is 
completed. Data for HIV/AIDS, when available, are displayed in Table IV, which appears quarterly.
 §§ Updated weekly from reports to the Influenza Division, National Center for Immunization and Respiratory Diseases. Since April 26, 2009, a total of 286 influenza-associated pediatric 
deaths associated with 2009 influenza A (H1N1) virus infection have been reported. Since August 30, 2009, a total of 281 influenza-associated pediatric deaths occurring during the 
2009–10 influenza season have been reported. A total of 133 influenza-associated pediatric deaths occurring during the 2008-09 influenza season have been reported.
 ¶¶ No measles cases were reported for the current week.
 *** Data for meningococcal disease (all serogroups) are available in Table II.
 ††† CDC discontinued reporting of individual confirmed and probable cases of 2009 pandemic influenza A (H1N1) virus infections on July 24, 2009. During 2009, three cases of novel 
influenza A virus infections, unrelated to the 2009 pandemic influenza A (H1N1) virus, were reported to CDC. The one case of novel influenza A virus infection reported to CDC during 
2010 was identified as swine influenza A (H3N2) virus and is unrelated to pandemic influenza A (H1N1) virus.  Total case count for 2009 was provided by the Influenza Division,  National 
Center for Immunization and Respiratory Diseases (NCIRD).
 §§§ In 2009, Q fever acute and chronic reporting categories were recognized as a result of revisions to the Q fever case definition. Prior to that time, case counts were not differentiated with 
respect to acute and chronic Q fever cases.
 ¶¶¶ No rubella cases were reported for the current week.
 **** Updated weekly from reports to the Division of Viral and Rickettsial Diseases, National Center for Zoonotic, Vector-Borne, and Enteric Diseases.
 †††† Updated weekly from reports to the Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
 §§§§ There was one case of viral hemorrhagic fever reported during week 12. The one case report was confirmed as lassa fever. See Table II for dengue hemorrhagic fever.
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TABLE II. Provisional cases of selected notifiable diseases, United States, weeks ending September 4, 2010, and September 5, 2009 (35th week)*
Reporting area
Chlamydia trachomatis infection Cryptosporidiosis
Current  
week






Previous 52 weeks Cum  
2010
Cum  
2009Med Max Med Max
United States 11,373 22,745 26,167 771,941 849,520 144 122 264 4,785 4,797
New England 687 740 1,396 26,135 27,291 2 8 58 300 307
Connecticut 276 220 736 6,617 7,809 — 0 52 52 38
Maine† — 50 75 1,640 1,625 1 1 7 58 34
Massachusetts 339 396 638 13,321 13,100 — 3 15 91 124
New Hampshire 52 40 116 1,571 1,445 — 1 5 40 58
Rhode Island† — 65 116 2,162 2,509 — 0 8 9 7
Vermont† 20 24 63 824 803 1 1 9 50 46
Mid. Atlantic 3,074 3,192 4,619 113,235 106,183 21 15 37 541 554
New Jersey 449 456 698 16,750 16,652 — 0 3 — 40
New York (Upstate) 899 674 2,530 22,922 20,433 11 3 16 141 137
New York City 1,134 1,194 2,144 42,239 39,495 — 1 5 50 64
Pennsylvania 592 882 1,091 31,324 29,603 10 9 26 350 313
E.N. Central 968 3,515 4,413 115,610 137,057 33 30 97 1,242 1,169
Illinois 18 851 1,322 24,129 41,865 — 3 15 136 110
Indiana — 345 786 12,343 16,145 — 4 10 133 199
Michigan 638 891 1,417 32,611 31,478 2 6 13 223 185
Ohio 144 959 1,077 32,663 33,249 18 7 24 311 278
Wisconsin 168 404 494 13,864 14,320 13 10 44 439 397
W.N. Central 260 1,333 1,592 44,670 48,470 37 23 59 856 705
Iowa 8 184 293 6,582 6,607 — 4 20 214 154
Kansas 19 187 235 6,334 7,446 4 2 9 100 69
Minnesota — 274 337 9,076 9,794 — 2 30 98 179
Missouri 161 489 606 16,379 17,729 20 4 23 231 135
Nebraska† 66 95 237 3,244 3,695 13 2 15 132 69
North Dakota — 34 93 1,083 1,149 — 0 18 16 7
South Dakota 6 60 82 1,972 2,050 — 2 8 65 92
S. Atlantic 2,401 4,472 5,681 151,423 173,013 32 19 51 691 717
Delaware 83 86 156 2,830 3,192 — 0 2 5 6
District of Columbia — 99 177 3,199 4,802 — 0 1 2 5
Florida 704 1,400 1,656 49,776 50,632 19 8 24 262 247
Georgia 317 395 1,323 11,341 27,780 9 5 31 207 250
Maryland† — 448 1,031 14,425 15,328 1 1 3 26 31
North Carolina — 797 1,562 28,269 28,806 — 1 12 53 76
South Carolina† 560 516 693 18,205 18,637 2 1 8 56 43
Virginia† 684 594 902 20,928 21,341 1 2 8 69 49
West Virginia 53 70 137 2,450 2,495 — 0 2 11 10
E.S. Central 1,215 1,712 2,410 58,819 64,609 7 4 13 174 145
Alabama† 518 474 661 17,134 18,600 — 1 8 70 45
Kentucky 264 296 642 10,563 9,056 2 1 6 56 40
Mississippi 433 389 780 12,622 16,441 — 0 3 7 14
Tennessee† — 570 732 18,500 20,512 5 1 5 41 46
W.S. Central 1,092 2,905 4,578 99,911 111,666 7 8 39 234 352
Arkansas† — 240 402 7,042 9,796 — 1 4 22 36
Louisiana — 1 1,055 2,922 20,113 — 1 5 28 37
Oklahoma — 262 1,376 10,606 10,108 6 1 9 61 78
Texas† 1,092 2,233 3,201 79,341 71,649 1 4 30 123 201
Mountain 247 1,449 2,081 45,968 52,859 2 10 22 348 385
Arizona — 464 713 13,195 17,613 — 0 3 23 25
Colorado — 382 709 11,902 12,080 — 2 9 89 105
Idaho† — 63 191 1,985 2,499 2 2 6 60 58
Montana† 42 58 75 2,031 2,048 — 1 4 33 40
Nevada† — 177 337 6,381 7,049 — 0 2 14 15
New Mexico† 194 166 453 5,223 6,107 — 2 8 69 101
Utah 11 117 175 3,994 4,183 — 1 4 47 26
Wyoming† — 38 70 1,257 1,280 — 0 2 13 15
Pacific 1,429 3,454 5,350 116,170 128,372 3 12 27 399 463
Alaska — 107 147 3,907 3,623 — 0 1 2 5
California 1,429 2,745 4,406 93,950 98,423 3 8 19 229 261
Hawaii — 112 158 3,759 4,175 — 0 0 — 1
Oregon — 0 468 1,367 7,219 — 3 8 110 142
Washington — 394 497 13,187 14,932 — 2 8 58 54
Territories
American Samoa — 0 0 — — N 0 0 N N
C.N.M.I. — — — — — — — — — —
Guam — 5 31 179 263 — 0 0 — —
Puerto Rico 85 95 265 3,598 5,272 N 0 0 N N
U.S. Virgin Islands — 9 29 323 364 — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional. Data for HIV/AIDS, AIDS, and TB, when available, are displayed in Table IV, which appears quarterly.
† Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending September 4, 2010, and September 5, 2009 (35th week)*
Dengue Virus Infection
Reporting area
Dengue Fever† Dengue Hemorrhagic Fever§
Current  
week






Previous 52 weeks Cum  
2010
Cum  
2009Med Max Med Max
United States — 2 21 232 NN — 0 1 2 NN
New England — 0 1 2 NN — 0 0 — NN
Connecticut — 0 0 — NN — 0 0 — NN
Maine¶ — 0 1 1 NN — 0 0 — NN
Massachusetts — 0 0 — NN — 0 0 — NN
New Hampshire — 0 0 — NN — 0 0 — NN
Rhode Island¶ — 0 0 — NN — 0 0 — NN
Vermont¶ — 0 1 1 NN — 0 0 — NN
Mid. Atlantic — 0 7 60 NN — 0 0 — NN
New Jersey — 0 0 — NN — 0 0 — NN
New York (Upstate) — 0 0 — NN — 0 0 — NN
New York City — 0 5 50 NN — 0 0 — NN
Pennsylvania — 0 2 10 NN — 0 0 — NN
E.N. Central — 0 2 22 NN — 0 0 — NN
Illinois — 0 0 — NN — 0 0 — NN
Indiana — 0 2 7 NN — 0 0 — NN
Michigan — 0 1 4 NN — 0 0 — NN
Ohio — 0 2 8 NN — 0 0 — NN
Wisconsin — 0 1 3 NN — 0 0 — NN
W.N. Central — 0 3 13 NN — 0 0 — NN
Iowa — 0 1 1 NN — 0 0 — NN
Kansas — 0 0 — NN — 0 0 — NN
Minnesota — 0 2 10 NN — 0 0 — NN
Missouri — 0 1 2 NN — 0 0 — NN
Nebraska¶ — 0 0 — NN — 0 0 — NN
North Dakota — 0 0 — NN — 0 0 — NN
South Dakota — 0 0 — NN — 0 0 — NN
S. Atlantic — 0 14 116 NN — 0 1 1 NN
Delaware — 0 0 — NN — 0 0 — NN
District of Columbia — 0 0 — NN — 0 0 — NN
Florida — 0 13 99 NN — 0 1 1 NN
Georgia — 0 2 6 NN — 0 0 — NN
Maryland¶ — 0 0 — NN — 0 0 — NN
North Carolina — 0 1 1 NN — 0 0 — NN
South Carolina¶ — 0 3 8 NN — 0 0 — NN
Virginia¶ — 0 0 — NN — 0 0 — NN
West Virginia — 0 1 2 NN — 0 0 — NN
E.S. Central — 0 1 1 NN — 0 0 — NN
Alabama¶ — 0 0 — NN — 0 0 — NN
Kentucky — 0 0 — NN — 0 0 — NN
Mississippi — 0 0 — NN — 0 0 — NN
Tennessee¶ — 0 1 1 NN — 0 0 — NN
W.S. Central — 0 1 1 NN — 0 1 1 NN
Arkansas¶ — 0 0 — NN — 0 1 1 NN
Louisiana — 0 0 — NN — 0 0 — NN
Oklahoma — 0 1 1 NN — 0 0 — NN
Texas¶ — 0 0 — NN — 0 0 — NN
Mountain — 0 1 8 NN — 0 0 — NN
Arizona — 0 1 2 NN — 0 0 — NN
Colorado — 0 0 — NN — 0 0 — NN
Idaho¶ — 0 0 — NN — 0 0 — NN
Montana¶ — 0 1 2 NN — 0 0 — NN
Nevada¶ — 0 1 3 NN — 0 0 — NN
New Mexico¶ — 0 1 1 NN — 0 0 — NN
Utah — 0 0 — NN — 0 0 — NN
Wyoming¶ — 0 0 — NN — 0 0 — NN
Pacific — 0 2 9 NN — 0 0 — NN
Alaska — 0 0 — NN — 0 0 — NN
California — 0 1 4 NN — 0 0 — NN
Hawaii — 0 0 — NN — 0 0 — NN
Oregon — 0 0 — NN — 0 0 — NN
Washington — 0 2 5 NN — 0 0 — NN
Territories
American Samoa — 0 0 — NN — 0 0 — NN
C.N.M.I. — — — — NN — — — — NN
Guam — 0 0 — NN — 0 0 — NN
Puerto Rico — 17 83 1,114 NN — 0 3 27 NN
U.S. Virgin Islands — 0 0 — NN — 0 0 — NN
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Dengue Fever includes cases that meet criteria for Dengue Fever with hemorrhage.
§ DHF includes cases that meet criteria for dengue shock syndrome (DSS), a more severe form of DHF.
¶ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending September 4, 2010, and September 5, 2009 (35th week)*
Ehrlichiosis/Anaplasmosis†
Reporting area
Ehrlichia chaffeensis Anaplasma phagocytophilum Undetermined
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 4 12 181 433 685 11 14 309 437 668 1 2 35 71 139
New England — 0 3 3 36 — 1 17 50 202 — 0 2 6 2
Connecticut — 0 0 — — — 0 13 18 2 — 0 2 4 —
Maine§ — 0 1 2 3 — 0 2 13 12 — 0 0 — —
Massachusetts — 0 0 — 9 — 0 4 — 82 — 0 0 — —
New Hampshire — 0 1 1 3 — 0 3 8 15 — 0 1 2 1
Rhode Island§ — 0 2 — 20 — 0 7 11 91 — 0 0 — 1
Vermont§ — 0 0 — 1 — 0 0 — — — 0 0 — —
Mid. Atlantic 1 1 15 33 122 10 3 17 136 204 — 0 2 3 40
New Jersey — 0 6 — 74 — 0 2 1 60 — 0 0 — —
New York (Upstate) 1 1 15 18 30 10 3 17 133 139 — 0 1 3 4
New York City — 0 3 14 7 — 0 1 2 4 — 0 0 — 1
Pennsylvania — 0 5 1 11 — 0 1 — 1 — 0 2 — 35
E.N. Central — 0 4 21 73 — 2 27 183 235 1 1 4 41 59
Illinois — 0 2 9 32 — 0 0 — 6 — 0 2 3 3
Indiana — 0 0 — — — 0 0 — — 1 0 3 23 32
Michigan — 0 1 1 4 — 0 0 — — — 0 1 2 —
Ohio — 0 3 5 10 — 0 1 1 1 — 0 0 — 2
Wisconsin — 0 3 6 27 — 2 27 182 228 — 0 3 13 22
W.N. Central 1 2 12 105 129 — 0 261 8 7 — 0 30 11 16
Iowa — 0 0 — — — 0 0 — — — 0 0 — —
Kansas — 0 1 6 6 — 0 0 — 1 — 0 0 — —
Minnesota — 0 6 — 1 — 0 261 — 3 — 0 30 — 3
Missouri 1 1 12 98 120 — 0 3 8 2 — 0 3 11 13
Nebraska§ — 0 1 1 2 — 0 1 — 1 — 0 0 — —
North Dakota — 0 0 — — — 0 0 — — — 0 0 — —
South Dakota — 0 0 — — — 0 0 — — — 0 0 — —
S. Atlantic 2 4 19 187 190 1 0 7 43 14 — 0 1 3 2
Delaware — 0 3 16 15 — 0 1 4 2 — 0 0 — —
District of Columbia — 0 0 — — — 0 0 — — — 0 0 — —
Florida 1 0 2 8 8 — 0 1 2 3 — 0 0 — —
Georgia — 0 4 15 17 — 0 1 1 1 — 0 1 1 —
Maryland§ — 0 3 18 33 — 0 2 11 3 — 0 1 2 —
North Carolina — 1 13 69 48 — 0 4 16 3 — 0 0 — —
South Carolina§ — 0 2 3 8 — 0 0 — — — 0 0 — —
Virginia§ 1 1 13 58 60 1 0 2 9 2 — 0 0 — 2
West Virginia — 0 0 — 1 — 0 0 — — — 0 1 — —
E.S. Central — 1 10 66 104 — 0 2 15 3 — 0 2 6 20
Alabama§ — 0 3 10 6 — 0 2 6 1 — 0 0 — —
Kentucky — 0 2 10 9 — 0 0 — — — 0 0 — —
Mississippi — 0 1 2 6 — 0 1 1 — — 0 0 — —
Tennessee§ — 1 10 44 83 — 0 2 8 2 — 0 2 6 20
W.S. Central — 0 141 17 28 — 0 23 2 1 — 0 1 1 —
Arkansas§ — 0 34 2 4 — 0 6 — — — 0 0 — —
Louisiana — 0 1 1 — — 0 0 — — — 0 0 — —
Oklahoma — 0 105 11 23 — 0 16 2 1 — 0 0 — —
Texas§ — 0 2 3 1 — 0 1 — — — 0 1 1 —
Mountain — 0 0 — — — 0 0 — — — 0 1 — —
Arizona — 0 0 — — — 0 0 — — — 0 1 — —
Colorado — 0 0 — — — 0 0 — — — 0 0 — —
Idaho§ — 0 0 — — — 0 0 — — — 0 0 — —
Montana§ — 0 0 — — — 0 0 — — — 0 0 — —
Nevada§ — 0 0 — — — 0 0 — — — 0 0 — —
New Mexico§ — 0 0 — — — 0 0 — — — 0 0 — —
Utah — 0 0 — — — 0 0 — — — 0 0 — —
Wyoming§ — 0 0 — — — 0 0 — — — 0 0 — —
Pacific — 0 1 1 3 — 0 0 — 2 — 0 1 — —
Alaska — 0 0 — — — 0 0 — — — 0 0 — —
California — 0 1 1 3 — 0 0 — 2 — 0 1 — —
Hawaii — 0 0 — — — 0 0 — — — 0 0 — —
Oregon — 0 0 — — — 0 0 — — — 0 0 — —
Washington — 0 0 — — — 0 0 — — — 0 0 — —
Territories
American Samoa — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 0 — — — 0 0 — — — 0 0 — —
Puerto Rico — 0 0 — — — 0 0 — — — 0 0 — —
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Cumulative total E. ewingii cases reported for year 2010 = 10.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending September 4, 2010, and September 5, 2009 (35th week)*
Reporting area
Giardiasis Gonorrhea
Haemophilus influenzae, invasive†  
All ages, all serotypes
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 241 338 666 11,404 12,170 2,953 5,397 6,656 179,856 206,338 20 58 171 1,997 2,053
New England 1 31 65 960 1,094 153 99 196 3,484 3,232 — 3 21 111 139
Connecticut — 5 15 174 194 80 44 169 1,556 1,483 — 0 15 24 41
Maine§ 1 4 11 133 149 — 3 11 120 89 — 0 2 9 16
Massachusetts — 13 33 393 466 69 42 72 1,493 1,329 — 2 8 58 65
New Hampshire — 3 11 99 137 4 2 7 104 73 — 0 2 7 7
Rhode Island§ — 1 7 35 38 — 5 13 166 228 — 0 1 7 6
Vermont§ — 4 14 126 110 — 0 17 45 30 — 0 1 6 4
Mid. Atlantic 70 61 112 1,971 2,224 716 672 941 23,245 21,078 4 11 34 398 402
New Jersey — 6 15 192 299 87 99 151 3,552 3,222 — 2 7 58 93
New York (Upstate) 54 23 84 743 809 203 104 422 3,698 3,787 2 3 20 106 101
New York City 4 16 31 557 563 273 224 394 8,118 7,398 — 2 6 80 45
Pennsylvania 12 15 37 479 553 153 217 282 7,877 6,671 2 4 9 154 163
E.N. Central 23 52 92 1,791 1,903 282 975 1,536 31,446 43,711 4 9 20 339 319
Illinois — 11 22 362 423 5 191 441 5,509 13,985 — 2 9 97 124
Indiana — 6 14 191 181 — 93 214 3,481 5,216 — 1 6 65 55
Michigan 5 13 25 433 434 168 249 502 9,155 10,168 — 0 4 25 17
Ohio 16 17 28 558 533 60 315 372 10,290 10,768 4 2 6 83 73
Wisconsin 2 7 22 247 332 49 92 154 3,011 3,574 — 2 5 69 50
W.N. Central 25 26 165 966 1,117 90 274 367 9,028 10,235 2 3 24 117 119
Iowa 4 5 11 197 210 — 31 53 1,092 1,155 — 0 1 1 —
Kansas 1 4 8 151 110 4 39 83 1,308 1,764 — 0 2 12 13
Minnesota — 0 135 136 250 — 41 64 1,265 1,582 — 0 17 25 40
Missouri 14 8 16 257 356 63 123 172 4,313 4,479 — 1 6 55 43
Nebraska§ 6 4 9 156 117 23 22 50 761 930 1 0 2 15 18
North Dakota — 0 8 16 8 — 2 11 76 86 1 0 4 9 5
South Dakota — 1 10 53 66 — 6 16 213 239 — 0 0 — —
S. Atlantic 70 75 143 2,541 2,397 710 1,297 1,651 43,945 51,425 8 14 27 533 559
Delaware — 0 5 22 18 17 19 34 655 631 — 0 1 5 3
District of Columbia — 1 4 23 45 — 39 65 1,234 1,888 — 0 1 2 2
Florida 53 38 87 1,400 1,285 201 378 464 13,375 14,693 6 3 9 128 174
Georgia — 13 51 485 489 117 147 494 3,978 9,279 1 3 9 131 107
Maryland§ 6 6 12 185 180 — 128 237 4,184 4,140 1 1 6 42 67
North Carolina N 0 0 N N — 254 596 9,440 9,841 — 2 9 90 67
South Carolina§ 4 3 7 98 64 194 153 230 5,480 5,782 — 2 7 62 52
Virginia§ 7 9 36 306 284 168 161 271 5,262 4,813 — 2 4 57 63
West Virginia — 0 5 22 32 13 8 20 337 358 — 0 5 16 24
E.S. Central — 5 22 154 272 359 473 698 16,082 18,620 — 3 12 120 130
Alabama§ — 4 8 102 136 154 137 217 5,038 5,281 — 0 3 20 32
Kentucky N 0 0 N N 70 76 156 2,745 2,631 — 0 2 24 18
Mississippi N 0 0 N N 135 111 216 3,526 5,135 — 0 2 9 7
Tennessee§ — 2 18 52 136 — 149 195 4,773 5,573 — 2 10 67 73
W.S. Central — 8 18 230 334 315 772 1,227 26,528 32,669 1 2 20 92 87
Arkansas§ — 2 9 75 93 — 72 139 2,152 3,028 — 0 3 12 15
Louisiana — 3 9 92 134 — 0 343 910 6,542 — 0 3 17 16
Oklahoma — 2 7 63 107 — 80 359 3,040 3,203 1 1 15 56 53
Texas§ N 0 0 N N 315 572 962 20,426 19,896 — 0 2 7 3
Mountain 4 30 60 1,017 1,097 35 168 266 5,430 6,249 1 5 15 211 184
Arizona 1 3 7 97 136 — 59 109 1,549 2,065 1 2 10 80 59
Colorado — 13 27 457 331 — 51 127 1,675 1,861 — 1 5 63 52
Idaho§ — 4 9 131 122 — 1 6 53 73 — 0 2 12 3
Montana§ 3 2 11 73 83 1 2 6 78 51 — 0 1 2 1
Nevada§ — 1 11 54 80 — 29 94 1,147 1,238 — 0 2 5 14
New Mexico§ — 2 5 60 95 34 20 41 696 715 — 1 5 28 26
Utah — 4 12 121 207 — 6 15 208 197 — 0 4 16 26
Wyoming§ — 1 5 24 43 — 1 4 24 49 — 0 2 5 3
Pacific 48 53 133 1,774 1,732 293 581 796 20,668 19,119 — 2 9 76 114
Alaska — 2 7 65 69 — 23 36 831 643 — 0 2 15 13
California 38 33 61 1,130 1,149 293 484 700 17,561 15,713 — 0 4 12 39
Hawaii 2 0 4 18 14 — 13 24 468 427 — 0 2 4 26
Oregon 8 9 15 297 259 — 0 43 106 748 — 1 5 41 33
Washington — 9 75 264 241 — 48 66 1,702 1,588 — 0 4 4 3
Territories
American Samoa — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 1 2 3 — 0 4 20 14 — 0 0 — —
Puerto Rico — 1 7 18 118 6 5 14 179 173 — 0 1 1 4
U.S. Virgin Islands — 0 0 — — — 1 7 78 92 — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Data for H. influenzae (age <5 yrs for serotype b, nonserotype b, and unknown serotype) are available in Table I.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending September 4, 2010, and September 5, 2009 (35th week)*

















Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 20 30 69 989 1,364 34 59 204 2,001 2,246 11 15 44 556 506
New England — 2 5 66 75 — 1 5 37 40 — 1 4 22 48
Connecticut — 0 2 18 16 — 0 2 11 11 — 0 3 15 37
Maine† — 0 1 7 1 — 0 2 11 9 — 0 1 — 1
Massachusetts — 1 4 34 47 — 0 2 8 16 — 0 1 7 9
New Hampshire — 0 1 1 6 — 0 2 5 4 N 0 0 N N
Rhode Island† — 0 4 6 3 U 0 0 U U U 0 0 U U
Vermont† — 0 0 — 2 — 0 1 2 — — 0 0 — 1
Mid. Atlantic — 4 10 129 192 1 5 10 204 241 1 2 6 72 69
New Jersey — 0 3 11 54 — 1 5 51 73 — 0 2 7 4
New York (Upstate) — 1 3 38 34 — 1 6 37 38 1 1 4 42 33
New York City — 1 4 45 59 — 2 4 61 47 — 0 1 — 4
Pennsylvania — 1 6 35 45 1 1 5 55 83 — 0 3 23 28
E.N. Central 3 4 8 129 218 4 8 15 295 315 — 2 8 104 66
Illinois — 1 3 28 100 — 2 6 62 79 — 0 1 1 4
Indiana — 0 2 15 15 — 1 5 40 50 — 0 2 18 13
Michigan — 1 4 37 51 2 2 6 81 98 — 1 6 71 23
Ohio 3 0 5 27 30 2 2 6 79 70 — 0 1 8 23
Wisconsin — 0 3 22 22 — 1 3 33 18 — 0 1 6 3
W.N. Central 4 1 12 51 81 2 2 15 76 94 1 0 11 16 9
Iowa — 0 3 5 26 — 0 2 11 26 — 0 4 1 3
Kansas — 0 2 10 7 — 0 2 4 5 — 0 0 — 1
Minnesota — 0 12 13 14 — 0 13 6 17 — 0 9 9 2
Missouri — 0 2 15 14 1 1 3 44 31 1 0 1 4 —
Nebraska† 4 0 1 8 17 1 0 2 10 13 — 0 1 2 2
North Dakota — 0 1 — — — 0 0 — — — 0 1 — —
South Dakota — 0 0 — 3 — 0 1 1 2 — 0 0 — 1
S. Atlantic 4 8 14 245 287 13 17 40 588 616 3 4 7 120 115
Delaware — 0 1 5 3 — 0 2 18 23 U 0 0 U U
District of Columbia — 0 1 1 1 — 0 1 3 9 — 0 1 2 1
Florida 4 3 8 90 122 9 5 11 206 200 2 1 4 40 27
Georgia — 1 3 28 34 3 3 7 101 102 — 0 2 6 29
Maryland† — 1 4 18 30 — 1 6 40 54 — 0 2 16 17
North Carolina — 0 5 41 33 — 1 15 65 80 — 1 3 32 14
South Carolina† — 1 4 26 41 — 1 4 38 38 — 0 0 — 1
Virginia† — 1 6 34 22 — 2 14 74 63 1 0 2 10 7
West Virginia — 0 2 2 1 1 0 14 43 47 — 0 5 14 19
E.S. Central — 1 3 27 31 5 7 13 228 223 1 3 7 91 66
Alabama† — 0 1 5 7 — 1 5 41 67 — 0 2 3 5
Kentucky — 0 2 12 7 5 2 7 80 51 — 2 5 63 40
Mississippi — 0 1 1 8 — 1 3 22 19 U 0 0 U U
Tennessee† — 0 2 9 9 — 3 7 85 86 1 0 4 25 21
W.S. Central — 2 19 73 134 7 9 109 290 388 5 1 14 52 40
Arkansas† — 0 3 — 6 — 1 4 31 49 — 0 1 — 1
Louisiana — 0 2 6 4 — 1 5 30 43 — 0 1 4 6
Oklahoma — 0 3 — 3 3 1 19 61 69 4 0 12 19 10
Texas† — 2 18 67 121 4 5 87 168 227 1 1 3 29 23
Mountain 1 3 8 107 111 — 2 8 84 96 — 1 5 33 36
Arizona 1 1 5 49 46 — 0 2 22 35 U 0 0 U U
Colorado — 1 3 24 38 — 0 3 18 18 — 0 2 6 23
Idaho† — 0 2 6 3 — 0 1 6 8 — 0 2 8 2
Montana† — 0 1 4 5 — 0 1 1 — — 0 0 — 1
Nevada† — 0 2 11 7 — 1 3 29 22 — 0 1 3 2
New Mexico† — 0 1 3 7 — 0 1 3 5 — 0 2 7 5
Utah — 0 2 7 3 — 0 1 5 4 — 0 1 9 3
Wyoming† — 0 3 3 2 — 0 0 — 4 — 0 0 — —
Pacific 8 5 16 162 235 2 6 20 199 233 — 1 6 46 57
Alaska — 0 1 1 2 — 0 1 2 2 U 0 2 U U
California 8 4 15 133 184 2 4 17 138 165 — 0 4 21 29
Hawaii — 0 2 1 8 — 0 1 — 5 U 0 0 U U
Oregon — 0 2 13 10 — 1 4 30 28 — 0 3 10 15
Washington — 0 2 14 31 — 1 4 29 33 — 0 6 15 13
Territories
American Samoa — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 6 14 4 — 1 6 30 42 — 0 6 25 33
Puerto Rico — 0 1 3 20 — 0 5 10 21 — 0 0 — —
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending September 4, 2010, and September 5, 2009 (35th week)*
Reporting area
Legionellosis Lyme disease Malaria
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 39 61 111 1,905 2,172 196 438 2,336 16,955 28,578 20 24 89 873 960
New England — 3 10 116 145 8 124 363 4,591 10,086 — 1 4 44 42
Connecticut — 0 3 23 40 — 40 179 1,624 3,478 — 0 1 1 5
Maine† — 0 1 7 6 7 12 76 416 570 — 0 1 5 2
Massachusetts — 1 7 67 73 — 41 127 1,460 4,426 — 1 3 30 26
New Hampshire — 0 3 7 10 1 22 58 821 1,103 — 0 1 2 3
Rhode Island† — 0 3 5 10 — 1 11 35 194 — 0 1 4 3
Vermont† — 0 2 7 6 — 4 26 235 315 — 0 1 2 3
Mid. Atlantic 15 16 44 463 791 132 190 635 8,422 12,360 2 7 17 230 274
New Jersey — 2 13 47 146 — 44 167 2,028 4,155 — 0 4 1 72
New York (Upstate) 9 5 19 162 236 74 55 577 2,043 2,797 1 1 4 48 36
New York City — 2 12 72 158 — 0 37 9 790 — 4 12 143 125
Pennsylvania 6 6 16 182 251 58 73 352 4,342 4,618 1 1 3 38 41
E.N. Central 8 12 33 439 454 3 22 118 1,133 2,483 — 2 9 90 133
Illinois — 2 11 73 78 — 0 9 52 119 — 1 7 29 56
Indiana 4 2 6 65 38 — 1 7 59 69 — 0 2 7 20
Michigan — 3 18 101 94 — 1 14 76 77 — 0 4 19 20
Ohio 4 5 12 157 190 3 1 5 25 31 — 0 5 31 29
Wisconsin — 1 11 43 54 — 18 104 921 2,187 — 0 1 4 8
W.N. Central 1 2 19 78 82 — 3 1,395 91 190 2 1 11 45 44
Iowa — 0 3 9 19 — 0 10 66 99 — 0 1 8 10
Kansas — 0 2 6 5 — 0 1 6 16 — 0 2 7 6
Minnesota — 0 16 23 8 — 0 1,380 — 68 — 0 11 3 13
Missouri — 0 4 24 39 — 0 1 1 3 1 0 3 12 9
Nebraska† 1 0 2 8 9 — 0 2 9 3 1 0 2 13 5
North Dakota — 0 1 4 1 — 0 15 8 — — 0 1 — —
South Dakota — 0 1 4 1 — 0 1 1 1 — 0 2 2 1
S. Atlantic 10 11 25 349 335 46 60 156 2,467 3,152 7 6 36 242 254
Delaware — 0 3 12 12 2 12 31 478 773 — 0 1 2 3
District of Columbia — 0 4 12 14 — 0 4 18 46 — 0 3 7 10
Florida 6 4 10 124 108 2 2 11 57 45 2 2 7 88 69
Georgia — 1 4 31 32 — 0 2 8 36 — 0 2 3 57
Maryland† 2 3 12 72 88 5 28 73 1,029 1,571 4 1 19 58 55
North Carolina — 1 7 36 39 — 1 9 65 74 — 0 13 33 19
South Carolina† 1 0 2 9 6 — 1 3 26 25 — 0 1 3 3
Virginia† 1 1 6 44 32 37 14 79 708 510 1 1 5 47 36
West Virginia — 0 3 9 4 — 0 33 78 72 — 0 2 1 2
E.S. Central — 2 10 90 90 — 1 4 31 24 — 0 3 20 28
Alabama† — 0 2 9 11 — 0 1 — 2 — 0 1 3 8
Kentucky — 0 4 19 36 — 0 1 2 1 — 0 3 5 8
Mississippi — 0 3 8 4 — 0 0 — — — 0 2 2 3
Tennessee† — 1 6 54 39 — 1 4 29 21 — 0 2 10 9
W.S. Central 1 3 14 83 72 1 2 44 46 128 — 1 31 53 44
Arkansas† — 0 2 11 5 — 0 0 — — — 0 1 1 3
Louisiana — 0 3 5 7 — 0 0 — — — 0 1 1 5
Oklahoma 1 0 4 11 3 — 0 2 — — — 0 1 4 1
Texas† — 2 10 56 57 1 2 42 46 128 — 1 30 47 35
Mountain 1 3 10 107 84 — 0 3 15 47 — 1 3 40 41
Arizona 1 1 5 35 31 — 0 1 3 4 — 0 2 18 7
Colorado — 1 5 24 12 — 0 1 2 1 — 0 1 12 23
Idaho† — 0 1 3 3 — 0 1 5 13 — 0 1 1 2
Montana† — 0 1 4 5 — 0 0 — 3 — 0 1 2 5
Nevada† — 0 2 18 10 — 0 1 — 12 — 0 1 3 —
New Mexico† — 0 2 6 3 — 0 1 3 4 — 0 1 1 —
Utah — 0 3 13 19 — 0 1 2 8 — 0 1 3 4
Wyoming† — 0 2 4 1 — 0 1 — 2 — 0 0 — —
Pacific 3 5 19 180 119 6 5 10 159 108 9 3 19 109 100
Alaska — 0 2 2 1 — 0 1 4 5 — 0 1 2 2
California 3 3 19 153 92 5 3 9 110 68 9 2 13 78 75
Hawaii — 0 1 1 1 N 0 0 N N — 0 1 1 1
Oregon — 0 3 9 10 1 1 3 38 30 — 0 1 7 9
Washington — 0 4 15 15 — 0 3 7 5 — 0 5 21 13
Territories
American Samoa — 0 0 — — N 0 0 N N — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 0 — — — 0 0 — — — 0 0 — —
Puerto Rico — 0 1 — 1 N 0 0 N N — 0 1 1 4
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending September 4, 2010, and September 5, 2009 (35th week)*
Reporting area
Meningococcal disease, invasive† 
All groups Pertussis Rabies, animal
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 5 16 43 524 667 258 291 1,756 11,024 10,621 47 72 147 2,357 3,638
New England — 0 2 13 24 — 8 17 256 480 4 4 24 163 240
Connecticut — 0 2 2 3 — 1 7 63 35 — 1 22 59 101
Maine§ — 0 1 3 3 — 0 5 25 70 1 1 4 42 38
Massachusetts — 0 1 3 12 — 4 10 135 279 — 0 0 — —
New Hampshire — 0 1 — 1 — 0 3 9 61 — 0 5 10 25
Rhode Island§ — 0 0 — 4 — 0 8 19 26 — 0 5 14 34
Vermont§ — 0 1 5 1 — 0 1 5 9 3 1 5 38 42
Mid. Atlantic — 1 4 44 75 36 21 62 821 826 15 17 41 735 422
New Jersey — 0 2 9 13 — 3 8 68 170 — 0 0 — —
New York (Upstate) — 0 3 9 16 11 7 27 307 131 9 9 22 367 310
New York City — 0 2 11 13 — 0 11 44 59 — 1 12 105 12
Pennsylvania — 0 2 15 33 25 8 38 402 466 6 5 24 263 100
E.N. Central 2 3 8 92 116 54 68 128 2,785 2,179 3 2 27 189 187
Illinois — 0 4 17 31 — 11 27 433 497 — 1 11 96 69
Indiana — 0 3 21 24 — 9 26 364 248 — 0 0 — 25
Michigan — 0 2 13 18 11 22 45 772 529 1 1 5 53 54
Ohio 2 1 2 23 26 42 20 69 987 774 2 0 12 40 39
Wisconsin — 0 2 18 17 1 5 12 229 131 — 0 0 — —
W.N. Central — 1 6 38 52 96 26 627 1,200 1,604 6 5 16 188 285
Iowa — 0 3 8 7 — 6 24 261 159 — 0 2 7 25
Kansas — 0 2 6 9 — 3 9 98 179 — 1 4 47 60
Minnesota — 0 2 2 10 89 0 601 425 336 2 1 9 26 40
Missouri — 0 3 16 18 2 8 25 242 777 2 1 6 56 48
Nebraska§ — 0 2 5 5 3 2 10 119 109 2 1 4 42 67
North Dakota — 0 1 1 1 2 0 30 32 17 — 0 7 10 4
South Dakota — 0 2 — 2 — 1 5 23 27 — 0 2 — 41
S. Atlantic 2 3 7 102 122 20 26 74 978 1,186 17 22 88 732 1,539
Delaware — 0 1 1 2 — 0 4 9 10 — 0 0 — —
District of Columbia — 0 0 — — — 0 1 4 4 — 0 0 — —
Florida 1 1 5 45 40 13 5 28 219 381 — 0 75 75 161
Georgia — 0 2 9 23 2 3 16 145 185 — 0 13 — 289
Maryland§ 1 0 1 5 7 2 2 8 76 102 — 6 15 220 280
North Carolina — 0 2 14 23 — 1 32 124 149 — 0 15 — 346
South Carolina§ — 0 1 9 11 — 5 19 239 195 — 0 0 — —
Virginia§ — 0 2 17 11 3 5 15 129 136 16 10 26 384 379
West Virginia — 0 2 2 5 — 0 7 33 24 1 2 6 53 84
E.S. Central 1 0 4 27 23 3 14 25 496 619 2 3 8 129 107
Alabama§ — 0 2 5 6 — 4 8 145 241 — 0 4 36 —
Kentucky 1 0 2 12 4 — 4 13 162 186 1 0 4 15 36
Mississippi — 0 1 3 3 — 1 6 44 51 — 0 3 15 4
Tennessee§ — 0 2 7 10 3 4 10 145 141 1 1 4 63 67
W.S. Central — 1 9 58 60 36 57 753 1,874 2,169 — 1 40 58 592
Arkansas§ — 0 2 5 5 3 4 29 114 256 — 0 10 20 28
Louisiana — 0 4 12 11 — 1 4 20 125 — 0 0 — —
Oklahoma — 0 7 14 6 3 0 41 31 36 — 0 30 38 21
Texas§ — 0 7 27 38 30 49 681 1,709 1,752 — 0 30 — 543
Mountain — 1 6 42 49 9 21 41 727 675 — 1 8 43 78
Arizona — 0 2 11 12 1 6 14 238 162 — 0 5 — —
Colorado — 0 4 13 14 — 3 13 125 177 — 0 0 — —
Idaho§ — 0 1 5 6 7 2 19 120 60 — 0 2 5 3
Montana§ — 0 1 1 5 — 1 8 33 23 — 0 4 10 24
Nevada§ — 0 1 8 4 1 0 7 19 19 — 0 1 3 5
New Mexico§ — 0 1 3 3 — 1 6 54 48 — 0 3 9 20
Utah — 0 1 1 1 — 4 10 133 165 — 0 2 2 7
Wyoming§ — 0 1 — 4 — 0 1 5 21 — 0 3 14 19
Pacific — 3 16 108 146 4 34 186 1,887 883 — 3 12 120 188
Alaska — 0 2 1 6 — 0 6 25 32 — 0 2 11 10
California — 2 13 70 93 — 22 163 1,393 428 — 3 12 99 167
Hawaii — 0 1 1 5 — 0 5 25 30 — 0 0 — —
Oregon — 1 3 24 29 4 6 15 238 198 — 0 2 10 11
Washington — 0 7 12 13 — 4 24 206 195 — 0 0 — —
Territories
American Samoa — 0 0 — — — 0 0 — — N 0 0 N N
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 0 — — — 0 2 — — — 0 0 — —
Puerto Rico — 0 1 — — — 0 0 — 1 — 1 3 32 28
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Data for meningococcal disease, invasive caused by serogroups A, C, Y, and W-135; serogroup B; other serogroup; and unknown serogroup are available in Table I.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending September 4, 2010, and September 5, 2009 (35th week)*
Reporting area
Salmonellosis Shiga toxin-producing E. coli (STEC)† Shigellosis
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 803 887 1,579 29,271 31,420 56 80 198 2,895 3,069 198 254 527 8,804 11,125
New England 2 29 335 1,467 1,720 2 3 37 136 187 — 5 43 213 268
Connecticut — 0 318 318 430 — 0 37 37 67 — 0 36 36 43
Maine§ 1 2 7 79 94 — 0 2 11 14 — 0 2 5 2
Massachusetts — 21 47 807 833 — 2 8 59 64 — 4 15 156 185
New Hampshire — 3 10 119 216 — 0 2 17 24 — 0 2 6 16
Rhode Island§ — 2 17 97 95 — 0 26 2 — — 0 3 9 17
Vermont§ 1 1 5 47 52 2 0 2 10 18 — 0 1 1 5
Mid. Atlantic 92 96 202 3,507 3,771 6 8 26 335 298 29 34 66 1,126 2,137
New Jersey — 15 42 445 804 — 1 4 36 77 — 6 17 200 465
New York (Upstate) 43 24 78 949 866 2 3 15 133 92 10 4 19 151 155
New York City 6 25 55 874 863 — 1 5 48 42 1 7 14 203 321
Pennsylvania 43 29 73 1,239 1,238 4 2 13 118 87 18 17 35 572 1,196
E.N. Central 48 82 230 3,399 3,725 7 12 35 476 548 6 26 235 1,168 2,037
Illinois — 26 111 1,126 1,046 — 2 8 76 130 — 9 228 639 471
Indiana — 10 53 367 443 — 1 8 67 71 — 1 5 31 54
Michigan 13 15 41 600 707 — 3 16 114 98 — 4 9 159 169
Ohio 35 24 47 943 1,025 7 2 11 111 100 6 6 23 229 931
Wisconsin — 10 40 363 504 — 3 8 108 149 — 4 14 110 412
W.N. Central 46 45 94 1,654 1,925 7 10 39 433 542 12 48 88 1,657 654
Iowa 2 7 36 357 308 — 2 15 118 124 — 1 5 39 45
Kansas 12 7 20 301 289 1 1 6 48 46 3 4 14 184 160
Minnesota — 5 32 178 417 — 1 14 31 141 — 0 6 14 53
Missouri 25 12 43 541 445 3 3 27 169 98 8 42 75 1,389 367
Nebraska§ 5 4 13 167 275 3 1 6 50 69 1 0 4 26 22
North Dakota 2 0 39 27 35 — 0 7 — 4 — 0 5 — 3
South Dakota — 2 6 83 156 — 0 5 17 60 — 0 2 5 4
S. Atlantic 406 266 532 8,533 8,297 14 13 30 458 444 67 40 85 1,544 1,712
Delaware 4 3 10 109 76 — 0 2 4 11 — 2 10 36 75
District of Columbia 1 2 4 52 65 — 0 1 5 2 — 0 4 20 18
Florida 225 126 277 3,617 3,507 10 4 13 155 110 47 13 49 687 303
Georgia 56 40 117 1,440 1,540 — 1 15 69 50 15 12 25 465 451
Maryland§ 46 15 46 667 523 3 2 6 59 59 1 3 8 81 305
North Carolina — 31 144 1,024 1,173 — 1 7 44 76 — 2 17 115 320
South Carolina§ 45 20 76 820 582 — 0 3 16 23 — 1 5 46 92
Virginia§ 29 18 68 680 674 1 2 15 92 95 4 2 15 93 142
West Virginia — 3 16 124 157 — 0 5 14 18 — 0 2 1 6
E.S. Central 17 51 118 1,867 2,034 3 4 11 161 154 2 12 40 459 593
Alabama§ — 14 40 444 558 — 0 4 33 38 — 3 10 96 109
Kentucky 6 8 29 343 336 — 1 6 36 55 — 4 28 179 143
Mississippi — 13 44 512 604 — 0 2 11 6 — 1 3 27 33
Tennessee§ 11 14 43 568 536 3 2 8 81 55 2 4 11 157 308
W.S. Central 49 113 547 3,066 3,542 8 5 68 171 201 48 46 251 1,526 2,097
Arkansas§ 15 10 36 417 404 2 1 5 38 26 2 1 9 37 236
Louisiana — 19 44 641 745 — 0 3 8 19 — 3 10 137 145
Oklahoma 25 10 46 379 419 2 0 27 15 21 7 6 96 193 186
Texas§ 9 62 477 1,629 1,974 4 3 41 110 135 39 35 144 1,159 1,530
Mountain 5 48 99 1,729 2,140 3 9 27 368 398 3 15 39 462 817
Arizona 2 18 41 555 709 — 1 5 40 47 3 8 25 244 592
Colorado — 11 23 394 452 — 2 18 140 126 — 2 6 75 64
Idaho§ 2 3 9 106 130 3 1 7 49 57 — 0 3 18 6
Montana§ 1 2 7 66 84 — 0 5 28 26 — 0 1 5 11
Nevada§ — 4 20 193 187 — 0 5 20 21 — 1 7 21 48
New Mexico§ — 5 13 181 273 — 1 4 28 26 — 2 8 75 80
Utah — 5 18 204 235 — 1 11 52 85 — 0 4 24 15
Wyoming§ — 1 9 30 70 — 0 2 11 10 — 0 2 — 1
Pacific 138 115 299 4,049 4,266 6 10 46 357 297 31 20 64 649 810
Alaska — 1 5 62 53 — 0 1 1 1 — 0 2 1 2
California 130 84 227 3,048 3,167 6 5 35 158 160 30 16 51 534 644
Hawaii 5 4 62 112 237 — 0 4 14 4 1 0 3 11 29
Oregon 3 8 48 379 315 — 1 11 63 46 — 1 4 36 38
Washington — 15 61 448 494 — 3 19 121 86 — 2 22 67 97
Territories
American Samoa — 1 1 2 — — 0 0 — — — 0 1 1 3
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 2 4 9 — 0 0 — — — 0 3 1 5
Puerto Rico 1 6 39 131 363 — 0 0 — — — 0 1 — 10
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Includes E. coli O157:H7; Shiga toxin-positive, serogroup non-O157; and Shiga toxin-positive, not serogrouped.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending September 4, 2010, and September 5, 2009 (35th week)*











Previous 52 weeks Cum  
2010
Cum  
2009Med Max Med Max
United States 2 2 14 107 116 14 15 421 926 1,058
New England — 0 0 — 2 — 0 1 1 9
Connecticut — 0 0 — — — 0 0 — —
Maine§ — 0 0 — — — 0 1 1 4
Massachusetts — 0 0 — 1 — 0 1 — 5
New Hampshire — 0 0 — — — 0 1 — —
Rhode Island§ — 0 0 — — — 0 0 — —
Vermont§ — 0 0 — 1 — 0 0 — —
Mid. Atlantic 1 0 2 14 9 — 1 5 39 78
New Jersey — 0 0 — 2 — 0 3 — 50
New York (Upstate) — 0 1 1 — — 0 3 10 11
New York City — 0 1 1 — — 0 4 19 6
Pennsylvania 1 0 2 12 7 — 0 1 10 11
E.N. Central — 0 1 4 8 1 0 8 60 74
Illinois — 0 1 2 1 — 0 5 19 45
Indiana — 0 1 2 3 1 0 5 32 8
Michigan — 0 1 — 3 — 0 2 3 1
Ohio — 0 0 — — — 0 2 5 16
Wisconsin — 0 0 — 1 — 0 1 1 4
W.N. Central 1 0 3 13 16 3 2 19 196 225
Iowa — 0 0 — 1 — 0 1 3 4
Kansas — 0 1 2 1 — 0 0 — —
Minnesota — 0 1 — 1 — 0 1 — 1
Missouri 1 0 3 10 6 3 2 18 188 216
Nebraska§ — 0 1 1 7 — 0 1 4 4
North Dakota — 0 0 — — — 0 1 1 —
South Dakota — 0 0 — — — 0 0 — —
S. Atlantic — 1 10 54 55 6 5 59 325 317
Delaware — 0 1 1 — — 0 2 14 15
District of Columbia — 0 0 — — — 0 1 — —
Florida — 0 1 2 — — 0 1 7 4
Georgia — 0 6 33 45 — 0 0 — —
Maryland§ — 0 1 2 2 — 0 4 28 32
North Carolina — 0 3 11 5 — 1 48 178 203
South Carolina§ — 0 1 1 3 — 0 2 10 15
Virginia§ — 0 2 4 — 6 1 11 88 46
West Virginia — 0 0 — — — 0 1 — 2
E.S. Central — 0 3 12 7 3 3 28 248 214
Alabama§ — 0 1 2 3 — 1 8 47 50
Kentucky — 0 2 6 1 — 0 0 — —
Mississippi — 0 0 — — — 0 1 3 9
Tennessee§ — 0 2 4 3 3 3 20 198 155
W.S. Central — 0 3 1 6 1 1 408 49 118
Arkansas§ — 0 1 — — — 0 110 20 62
Louisiana — 0 0 — — — 0 1 2 2
Oklahoma — 0 2 — 5 1 0 287 17 39
Texas§ — 0 1 1 1 — 0 11 10 15
Mountain — 0 2 2 12 — 0 2 7 23
Arizona — 0 2 — 6 — 0 1 2 11
Colorado — 0 0 — 1 — 0 0 — —
Idaho§ — 0 0 — — — 0 1 2 1
Montana§ — 0 1 2 4 — 0 1 1 6
Nevada§ — 0 0 — — — 0 0 — 1
New Mexico§ — 0 0 — — — 0 1 1 1
Utah — 0 0 — — — 0 1 1 1
Wyoming§ — 0 0 — 1 — 0 0 — 2
Pacific — 0 2 7 1 — 0 1 1 —
Alaska N 0 0 N N N 0 0 N N
California — 0 2 6 1 — 0 0 — —
Hawaii N 0 0 N N N 0 0 N N
Oregon — 0 1 1 — — 0 1 1 —
Washington — 0 0 — — — 0 0 — —
Territories
American Samoa N 0 0 N N N 0 0 N N
C.N.M.I. — — — — — — — — — —
Guam N 0 0 N N N 0 0 N N
Puerto Rico N 0 0 N N N 0 0 N N
U.S. Virgin Islands — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Illnesses with similar clinical presentation that result from Spotted fever group rickettsia infections are reported as Spotted fever rickettsioses. Rocky Mountain spotted fever (RMSF) caused 
by Rickettsia rickettsii, is the most common and well-known spotted fever.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending September 4, 2010, and September 5, 2009 (35th week)*
Streptococcus pneumoniae,† invasive disease
Reporting area
All ages Age <5 Syphilis, primary and secondary
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 58 188 492 9,987 2,097 4 50 156 1,560 1,601 87 235 413 7,703 9,568
New England — 7 100 564 38 — 1 24 74 50 3 7 22 291 224
Connecticut — 0 93 255 — — 0 22 24 — 1 1 10 58 42
Maine§ — 1 6 86 10 — 0 2 7 4 — 0 3 16 2
Massachusetts — 0 5 53 3 — 1 4 35 35 1 5 14 173 157
New Hampshire — 0 7 59 — — 0 2 3 8 1 0 1 14 13
Rhode Island§ — 0 34 53 14 — 0 2 2 1 — 0 4 28 10
Vermont§ — 1 6 58 11 — 0 1 3 2 — 0 2 2 —
Mid. Atlantic 3 13 54 857 127 — 7 48 245 207 28 33 45 1,154 1,225
New Jersey — 1 8 76 — — 1 5 39 33 2 4 12 152 160
New York (Upstate) — 3 12 114 51 — 3 19 83 93 2 2 11 94 84
New York City — 4 25 322 8 — 1 24 83 68 19 18 31 666 751
Pennsylvania 3 6 22 345 68 — 0 5 40 13 5 7 16 242 230
E.N. Central 9 31 98 2,022 477 — 8 18 254 268 — 27 46 869 1,041
Illinois — 1 7 70 — — 2 5 63 41 — 12 23 307 506
Indiana — 7 23 413 187 — 1 6 35 56 — 3 13 116 106
Michigan 4 7 27 477 19 — 2 6 57 50 — 3 12 145 162
Ohio 4 14 49 835 271 — 2 6 68 92 — 8 13 274 234
Wisconsin 1 5 22 227 — — 1 4 31 29 — 1 3 27 33
W.N. Central 1 8 182 584 138 — 2 12 104 134 4 5 13 194 217
Iowa — 0 0 — — — 0 0 — — — 0 2 9 16
Kansas 1 1 7 72 47 — 0 2 11 15 — 0 3 11 20
Minnesota — 0 179 287 34 — 0 10 44 60 — 1 9 71 50
Missouri — 2 9 81 48 — 0 3 28 37 4 3 8 98 123
Nebraska§ — 1 7 91 — — 0 2 12 10 — 0 1 5 5
North Dakota — 0 11 39 7 — 0 1 2 4 — 0 1 — 3
South Dakota — 0 3 14 2 — 0 2 7 8 — 0 0 — —
S. Atlantic 31 40 144 2,331 943 1 12 28 392 377 26 56 218 1,857 2,293
Delaware 2 0 3 27 15 — 0 2 — — — 0 2 4 22
District of Columbia — 0 4 21 17 — 0 2 7 3 — 2 8 89 125
Florida 18 18 89 1,073 550 1 3 18 146 134 2 19 32 659 715
Georgia 2 10 28 381 271 — 4 12 105 95 3 11 167 364 539
Maryland§ 4 5 25 336 4 — 1 6 39 59 — 6 11 190 197
North Carolina — 0 0 — — — 0 0 — — 5 8 31 252 386
South Carolina§ 5 5 25 363 — — 1 4 40 34 6 2 7 99 88
Virginia§ — 0 4 41 — — 1 4 39 34 10 4 22 197 217
West Virginia — 1 21 89 86 — 0 4 16 18 — 0 2 3 4
E.S. Central 2 17 50 874 202 — 2 8 83 98 10 18 39 602 795
Alabama§ — 0 0 — — — 0 0 — — 2 5 12 161 314
Kentucky — 2 16 132 55 — 0 2 10 7 4 2 13 90 46
Mississippi — 1 6 41 34 — 0 2 8 17 4 5 17 148 146
Tennessee§ 2 12 44 701 113 — 2 7 65 74 — 6 17 203 289
W.S. Central 11 17 90 1,278 85 3 6 41 205 237 11 35 71 1,049 1,944
Arkansas§ 1 2 9 119 41 — 0 3 11 32 — 4 14 107 156
Louisiana — 1 8 56 44 — 0 3 17 17 — 2 23 64 567
Oklahoma 1 0 5 36 — 1 1 5 36 40 — 1 6 52 61
Texas§ 9 13 82 1,067 — 2 3 34 141 148 11 25 42 826 1,160
Mountain 1 20 82 1,266 84 — 5 12 175 207 — 9 20 291 364
Arizona 1 7 51 588 — — 2 7 77 93 — 3 7 92 172
Colorado — 6 20 372 — — 1 4 48 30 — 2 5 76 66
Idaho§ — 0 2 11 — — 0 2 5 7 — 0 1 2 3
Montana§ — 0 2 13 — — 0 1 1 — — 0 1 1 —
Nevada§ — 1 4 54 34 — 0 1 5 7 — 1 10 70 63
New Mexico§ — 2 9 114 — — 0 4 14 24 — 1 4 30 37
Utah — 2 9 105 41 — 1 4 22 45 — 0 4 20 20
Wyoming§ — 0 1 9 9 — 0 1 3 1 — 0 0 — 3
Pacific — 4 14 211 3 — 0 7 28 23 5 40 64 1,396 1,465
Alaska — 1 9 80 — — 0 5 18 14 — 0 1 1 —
California — 2 12 131 — — 0 2 10 — 5 36 59 1,233 1,298
Hawaii — 0 1 — 3 — 0 1 — 9 — 0 3 24 24
Oregon — 0 0 — — — 0 0 — — — 0 5 6 41
Washington — 0 0 — — — 0 0 — — — 3 10 132 102
Territories
American Samoa — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 0 — — — 0 0 — — — 0 0 — —
Puerto Rico — 0 0 — — — 0 0 — — 10 3 16 158 144
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Includes drug resistant and susceptible cases of invasive Streptococcus pneumoniae disease among children <5 years and among all ages. Case definition: Isolation of S. pneumoniae from 
a normally sterile body site (e.g., blood or cerebrospinal fluid).
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending September 4, 2010, and September 5, 2009 (35th week)*
West Nile virus disease†
Reporting area
Varicella (chickenpox)§ Neuroinvasive Nonneuroinvasive¶
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 94 325 545 9,622 14,949 — 0 40 144 295 — 0 29 114 273
New England — 15 36 457 734 — 0 1 3 — — 0 2 2 —
Connecticut — 6 20 212 355 — 0 1 2 — — 0 2 2 —
Maine§ — 3 15 130 131 — 0 0 — — — 0 0 — —
Massachusetts — 0 1 — 3 — 0 1 1 — — 0 0 — —
New Hampshire — 2 8 85 145 — 0 0 — — — 0 0 — —
Rhode Island§ — 1 12 18 24 — 0 0 — — — 0 0 — —
Vermont§ — 0 10 12 76 — 0 0 — — — 0 0 — —
Mid. Atlantic 15 33 66 1,090 1,456 — 0 9 32 4 — 0 4 10 1
New Jersey — 9 30 394 301 — 0 2 3 3 — 0 0 — —
New York (Upstate) N 0 0 N N — 0 5 16 1 — 0 4 8 1
New York City — 0 0 — — — 0 3 12 — — 0 2 2 —
Pennsylvania 15 22 52 696 1,155 — 0 1 1 — — 0 0 — —
E.N. Central 25 108 176 3,245 4,655 — 0 3 5 8 — 0 3 5 4
Illinois 6 26 49 840 1,112 — 0 1 1 5 — 0 0 — —
Indiana§ 4 6 35 303 347 — 0 0 — 2 — 0 2 2 2
Michigan 3 35 62 983 1,325 — 0 2 3 — — 0 1 1 —
Ohio 12 28 56 899 1,435 — 0 1 1 — — 0 1 1 2
Wisconsin — 7 24 220 436 — 0 0 — 1 — 0 1 1 —
W.N. Central 11 13 40 423 985 — 0 3 10 22 — 0 8 28 59
Iowa N 0 0 N N — 0 0 — — — 0 1 1 5
Kansas§ — 4 18 96 416 — 0 1 — 4 — 0 1 2 7
Minnesota — 0 0 — — — 0 1 3 1 — 0 1 — 1
Missouri 8 7 23 275 472 — 0 1 2 3 — 0 1 — —
Nebraska§ N 0 0 N N — 0 1 4 8 — 0 5 9 33
North Dakota 3 0 26 31 57 — 0 0 — — — 0 1 4 1
South Dakota — 0 7 21 40 — 0 1 1 6 — 0 3 12 12
S. Atlantic 13 37 99 1,482 1,874 — 0 3 8 11 — 0 2 4 2
Delaware§ — 0 4 17 11 — 0 0 — — — 0 0 — —
District of Columbia — 0 4 15 26 — 0 0 — 2 — 0 0 — —
Florida§ 8 15 57 737 925 — 0 2 2 1 — 0 1 — 1
Georgia N 0 0 N N — 0 1 3 2 — 0 1 3 —
Maryland§ N 0 0 N N — 0 1 3 — — 0 1 1 1
North Carolina N 0 0 N N — 0 0 — — — 0 0 — —
South Carolina§ — 0 35 75 93 — 0 0 — 3 — 0 0 — —
Virginia§ — 11 34 337 511 — 0 1 — 3 — 0 0 — —
West Virginia 5 8 26 301 308 — 0 0 — — — 0 0 — —
E.S. Central 1 6 28 200 390 — 0 5 2 26 — 0 3 5 20
Alabama§ 1 6 27 193 387 — 0 1 1 — — 0 1 2 —
Kentucky N 0 0 N N — 0 1 — 2 — 0 0 — —
Mississippi — 0 2 7 3 — 0 3 1 22 — 0 2 3 16
Tennessee§ N 0 0 N N — 0 2 — 2 — 0 1 — 4
W.S. Central 20 58 285 1,963 3,783 — 0 12 13 95 — 0 2 3 29
Arkansas§ — 3 32 122 383 — 0 2 2 6 — 0 0 — —
Louisiana — 1 8 40 107 — 0 2 5 9 — 0 1 2 9
Oklahoma N 0 0 N N — 0 2 — 4 — 0 0 — 2
Texas§ 20 49 272 1,801 3,293 — 0 12 6 76 — 0 2 1 18
Mountain 9 22 37 727 986 — 0 12 52 68 — 0 13 41 104
Arizona — 0 0 — — — 0 10 48 12 — 0 9 29 5
Colorado§ 9 8 20 293 366 — 0 7 1 30 — 0 7 9 58
Idaho§ N 0 0 N N — 0 2 — 9 — 0 4 — 23
Montana§ — 3 17 153 122 — 0 0 — 2 — 0 1 — 2
Nevada§ N 0 0 N N — 0 0 — 7 — 0 0 — 5
New Mexico§ — 2 7 76 96 — 0 1 2 5 — 0 1 1 2
Utah — 6 22 192 402 — 0 1 — — — 0 0 — 1
Wyoming§ — 0 3 13 — — 0 1 1 3 — 0 2 2 8
Pacific — 1 5 35 86 — 0 12 19 61 — 0 4 16 54
Alaska — 0 5 29 52 — 0 0 — — — 0 0 — —
California — 0 0 — — — 0 8 19 38 — 0 4 16 33
Hawaii — 0 2 6 34 — 0 0 — — — 0 0 — —
Oregon N 0 0 N N — 0 1 — 1 — 0 1 — 9
Washington N 0 0 N N — 0 6 — 22 — 0 0 — 12
Territories
American Samoa N 0 0 N N — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 3 12 15 — 0 0 — — — 0 0 — —
Puerto Rico 8 5 30 188 402 — 0 0 — — — 0 0 — —
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional. Data for HIV/AIDS, AIDS, and TB, when available, are displayed in Table IV, which appears quarterly.
† Updated weekly from reports to the Division of Vector-Borne Infectious Diseases, National Center for Zoonotic, Vector-Borne, and Enteric Diseases (ArboNET Surveillance). Data for California 
serogroup, eastern equine, Powassan, St. Louis, and western equine diseases are available in Table I.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
¶ Not reportable in all states. Data from states where the condition is not reportable are excluded from this table, except starting in 2007 for the domestic arboviral diseases and influenza-
associated pediatric mortality, and in 2003 for SARS-CoV. Reporting exceptions are available at http://www.cdc.gov/ncphi/disss/nndss/phs/infdis.htm.
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TABLE III. Deaths in 122 U.S. cities,* week ending September 4, 2010 (35th week)
Reporting area
All causes, by age (years)
P&I† 
Total Reporting area




Ages ≥65 45–64 25–44 1–24 <1
All  
Ages ≥65 45–64 25–44 1–24 <1
New England 499 356 104 20 10 9 45 S. Atlantic 1,140 704 286 95 33 22 58
Boston, MA 132 82 38 6 3 3 14 Atlanta, GA 135 81 31 14 6 3 2
Bridgeport, CT 27 21 5 — 1 — 1 Baltimore, MD 148 82 48 12 3 3 14
Cambridge, MA 16 15 1 — — — 3 Charlotte, NC 113 84 19 6 3 1 12
Fall River, MA 24 19 4 1 — — 2 Jacksonville, FL 154 100 36 13 3 2 6
Hartford, CT 52 35 12 2 2 1 2 Miami, FL 99 74 19 2 4 — 3
Lowell, MA 15 8 4 3 — — 1 Norfolk, VA 54 25 17 8 4 — 1
Lynn, MA 4 1 1 1 1 — 1 Richmond, VA 44 23 15 2 2 2 —
New Bedford, MA 25 19 6 — — — 1 Savannah, GA 64 38 21 4 1 — 7
New Haven, CT 33 25 5 2 — 1 2 St. Petersburg, FL 51 28 8 11 2 2 3
Providence, RI 55 44 8 1 — 2 — Tampa, FL 146 103 33 5 2 3 5
Somerville, MA 6 4 2 — — — — Washington, D.C. 126 61 38 18 3 6 5
Springfield, MA 29 21 5 2 1 — 6 Wilmington, DE 6 5 1 — — — —
Waterbury, CT 22 21 1 — — — 3 E.S. Central 773 480 197 57 21 18 74
Worcester, MA 59 41 12 2 2 2 9 Birmingham, AL 159 106 34 15 2 2 12
Mid. Atlantic 1,680 1,180 367 80 31 22 68 Chattanooga, TN 63 39 19 — 2 3 6
Albany, NY 57 34 17 5 1 — 4 Knoxville, TN 87 56 24 6 1 — 11
Allentown, PA 17 14 1 1 1 — — Lexington, KY 51 31 14 2 1 3 6
Buffalo, NY 92 67 14 5 4 2 10 Memphis, TN 187 106 48 17 10 6 19
Camden, NJ 28 18 10 — — — — Mobile, AL 60 46 12 1 1 — 5
Elizabeth, NJ 12 8 2 1 1 — 1 Montgomery, AL 18 11 4 1 — 2 —
Erie, PA 41 33 7 — 1 — 6 Nashville, TN 148 85 42 15 4 2 15
Jersey City, NJ U U U U U U U W.S. Central 1,494 965 339 117 39 34 83
New York City, NY 985 701 212 49 12 11 28 Austin, TX 84 56 16 5 2 5 5
Newark, NJ 33 12 15 2 1 3 1 Baton Rouge, LA 69 45 8 13 3 — —
Paterson, NJ 10 9 1 — — — — Corpus Christi, TX 38 24 10 2 1 1 3
Philadelphia, PA 144 91 37 9 5 2 2 Dallas, TX 205 114 67 14 5 5 16
Pittsburgh, PA§ 26 17 7 1 1 — 1 El Paso, TX 147 101 29 9 6 2 3
Reading, PA 19 15 4 — — — 2 Fort Worth, TX U U U U U U U
Rochester, NY 64 44 13 2 3 2 4 Houston, TX 467 282 116 44 12 13 30
Schenectady, NY 20 18 2 — — — 1 Little Rock, AR 73 43 17 9 2 2 —
Scranton, PA 20 14 6 — — — 2 New Orleans, LA U U U U U U U
Syracuse, NY 53 43 8 1 1 — 1 San Antonio, TX 214 156 41 12 2 3 9
Trenton, NJ 19 13 3 1 — 2 1 Shreveport, LA 50 38 10 1 1 — 4
Utica, NY 16 13 3 — — — 1 Tulsa, OK 147 106 25 8 5 3 13
Yonkers, NY 24 16 5 3 — — 3 Mountain 938 578 238 74 24 22 49
E.N. Central 1,879 1,236 441 109 51 42 95 Albuquerque, NM 108 72 29 3 2 2 4
Akron, OH 50 30 17 — 1 2 1 Boise, ID 45 29 14 2 — — 3
Canton, OH 27 19 5 2 1 — 1 Colorado Springs, CO 59 41 12 3 1 2 2
Chicago, IL 222 144 57 14 5 2 14 Denver, CO 76 37 27 6 2 4 5
Cincinnati, OH 78 39 20 4 5 10 3 Las Vegas, NV 290 179 80 21 7 3 18
Cleveland, OH 239 180 49 9 1 — 11 Ogden, UT 49 28 12 8 1 — 3
Columbus, OH 249 157 56 22 8 6 18 Phoenix, AZ 167 84 52 20 5 5 7
Dayton, OH 112 77 24 7 2 2 9 Pueblo, CO 28 23 4 1 — — 2
Detroit, MI 139 80 42 12 3 2 1 Salt Lake City, UT 110 83 7 8 6 6 5
Evansville, IN 54 34 17 2 1 — 3 Tucson, AZ 6 2 1 2 — — —
Fort Wayne, IN 59 39 15 — 3 2 — Pacific 1,498 1,046 317 72 35 28 118
Gary, IN 15 8 3 3 — 1 — Berkeley, CA 15 7 4 1 — 3 1
Grand Rapids, MI 63 43 15 1 3 1 3 Fresno, CA 104 77 17 5 3 2 5
Indianapolis, IN 154 90 40 10 10 4 9 Glendale, CA 37 33 3 — 1 — 8
Lansing, MI 37 27 4 4 2 — 2 Honolulu, HI 69 51 14 3 — 1 9
Milwaukee, WI 73 40 22 6 1 4 6 Long Beach, CA 62 35 17 3 3 4 6
Peoria, IL 50 43 4 2 1 — 4 Los Angeles, CA 238 156 62 11 4 5 37
Rockford, IL 53 33 10 6 3 1 2 Pasadena, CA 32 25 5 1 — 1 3
South Bend, IN 52 41 7 — — 4 3 Portland, OR 122 88 20 7 7 — 2
Toledo, OH 92 65 22 4 1 — 2 Sacramento, CA 185 139 34 7 3 2 15
Youngstown, OH 61 47 12 1 — 1 3 San Diego, CA 34 26 8 — — — 3
W.N. Central 480 297 118 31 13 21 19 San Francisco, CA 114 76 30 4 3 1 6
Des Moines, IA 51 27 14 4 2 4 4 San Jose, CA 182 122 40 12 4 4 15
Duluth, MN 33 26 6 1 — — — Santa Cruz, CA 28 18 6 3 — 1 1
Kansas City, KS U U U U U U U Seattle, WA 100 69 19 6 3 3 2
Kansas City, MO 113 65 28 9 3 8 5 Spokane, WA 51 38 13 — — — 2
Lincoln, NE 34 23 9 2 — — 1 Tacoma, WA 125 86 25 9 4 1 3
Minneapolis, MN 51 30 16 1 3 1 1 Total¶ 10,381 6,842 2,407 655 257 218 609
Omaha, NE 67 42 16 5 — 4 —
St. Louis, MO 81 47 21 7 2 4 7
St. Paul, MN 50 37 8 2 3 — 1
Wichita, KS U U U U U U U
U: Unavailable.   —: No reported cases.   
* Mortality data in this table are voluntarily reported from 122 cities in the United States, most of which have populations of >100,000. A death is reported by the place of its occurrence and 
by the week that the death certificate was filed. Fetal deaths are not included.
† Pneumonia and influenza.
§ Because of changes in reporting methods in this Pennsylvania city, these numbers are partial counts for the current week. Complete counts will be available in 4 to 6 weeks.
¶ Total includes unknown ages.
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